{
    "abstract": "Background: This phase I trial evaluated the safety and immunogenicity of a candidate tuberculosis vaccination regimen, ChAdOx1 85A prime-MVA85A boost, previously demonstrated to be protective in animal studies, in healthy UK adults. Methods: We enrolled 42 healthy, BCG-vaccinated adults into 4 groups: low dose Starter Group (n = 6; ChAdOx1 85A alone), high dose groups; Group A (n = 12; ChAdOx1 85A), Group B (n = 12; ChAdOx1 85A prime \u2013 MVA85A boost) or Group C (n = 12; ChAdOx1 85A \u2013 ChAdOx1 85A prime \u2013 MVA85A boost). Safety was determined by collection of solicited and unsolicited vaccine-related adverse events (AEs). Immunogenicity was measured by antigen-specific ex-vivo IFN-\u03b3 ELISpot, IgG serum ELISA, and antigen-specific intracellular IFN-\u03b3, TNF-\u03b1, IL-2 and IL-17. Results: AEs were mostly mild/moderate, with no Serious Adverse Events. ChAdOx1 85A induced Ag85A-specific ELISpot and intracellular cytokine CD4+ and CD8+ T cell responses, which were not boosted by a second dose, but were boosted with MVA85A. Polyfunctional CD4+ T cells (IFN-\u03b3, TNF-\u03b1 and IL-2) and IFN-\u03b3+, TNF-\u03b1+ CD8+ T cells were induced by ChAdOx1 85A and boosted by MVA85A. ChAdOx1 85A induced serum Ag85A IgG responses which were boosted by MVA85A. Conclusion: A ChAdOx1 85A prime \u2013 MVA85A boost is well tolerated and immunogenic in healthy UK adults.",
    "bib_entries": {
        "b0005": null,
        "b0010": null,
        "b0015": {
            "authors": [
                {
                    "first": "Graham A.",
                    "initial": "G.A.",
                    "last": "Colditz"
                },
                {
                    "first": "Timothy F.",
                    "initial": "T.F.",
                    "last": "Brewer"
                },
                {
                    "first": "Catherine S.",
                    "initial": "C.S.",
                    "last": "Berkey"
                },
                {
                    "first": "Mary E.",
                    "initial": "M.E.",
                    "last": "Wilson"
                },
                {
                    "first": "Elisabeth",
                    "initial": "E.",
                    "last": "Burdick"
                },
                {
                    "first": "Harvey V.",
                    "initial": "H.V.",
                    "last": "Fineberg"
                },
                {
                    "first": "Frederick",
                    "initial": "F.",
                    "last": "Mosteller"
                }
            ],
            "doi": "10.1001/jama.1994.03510330076038",
            "firstpage": "698",
            "issn": "00987484",
            "lastpage": "702",
            "pmid": "8309034",
            "pub_year": 1994,
            "title": "Efficacy of BCG Vaccine in the Prevention of Tuberculosis: Meta-analysis of the Published Literature",
            "volume": "271"
        },
        "b0020": {
            "authors": [
                {
                    "first": "B. Bourdin",
                    "initial": "B.B.",
                    "last": "Trunz"
                },
                {
                    "first": "PEM",
                    "initial": "P.",
                    "last": "Fine"
                },
                {
                    "first": "C.",
                    "initial": "C.",
                    "last": "Dye"
                }
            ],
            "doi": "10.1016/S0140-6736(06)68507-3",
            "firstpage": "1173",
            "issn": "01406736",
            "lastpage": "1180",
            "pmid": "16616560",
            "pub_year": 2006,
            "title": "Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness",
            "volume": "367"
        },
        "b0025": {
            "authors": [
                {
                    "first": "Laura C.",
                    "initial": "L.C.",
                    "last": "Rodrigues"
                },
                {
                    "first": "Vinod K.",
                    "initial": "V.K.",
                    "last": "Diwan"
                },
                {
                    "first": "Jeremy G.",
                    "initial": "J.G.",
                    "last": "Wheeler"
                }
            ],
            "doi": "10.1093/ije/22.6.1154",
            "firstpage": "1154",
            "issn": "03005771",
            "lastpage": "1158",
            "pmid": "8144299",
            "pub_year": 1993,
            "title": "Protective effect of bcg against tuberculous meningitis and miliary tuberculosis: A meta-analysis",
            "volume": "22"
        },
        "b0030": {
            "authors": [
                {
                    "first": "Helen",
                    "initial": "H.",
                    "last": "McShane"
                },
                {
                    "first": "Ansar A.",
                    "initial": "A.A.",
                    "last": "Pathan"
                },
                {
                    "first": "Clare R.",
                    "initial": "C.R.",
                    "last": "Sander"
                },
                {
                    "first": "Nilu P.",
                    "initial": "N.P.",
                    "last": "Goonetilleke"
                },
                {
                    "first": "Helen A.",
                    "initial": "H.A.",
                    "last": "Fletcher"
                },
                {
                    "first": "Adrian V.S.",
                    "initial": "A.V.S.",
                    "last": "Hill"
                }
            ],
            "doi": "10.1016/j.tube.2004.09.015",
            "firstpage": "47",
            "issn": "14729792",
            "lastpage": "52",
            "pmid": "15687027",
            "pub_year": 2005,
            "title": "Boosting BCG with MVA85A: The first candidate subunit vaccine for tuberculosis in clinical trials",
            "volume": "85"
        },
        "b0035": {
            "authors": [
                {
                    "first": "Zhou",
                    "initial": "Z.",
                    "last": "Xing"
                },
                {
                    "first": "Thomas James",
                    "initial": "T.J.",
                    "last": "Carters"
                }
            ],
            "doi": "10.1586/14760584.6.4.539",
            "firstpage": "539",
            "issn": "14760584",
            "lastpage": "546",
            "pmid": "17669008",
            "pub_year": 2007,
            "title": "Heterologous boost vaccines for bacillus Calmette-Gu\u00e9rin prime immunization against tuberculosis",
            "volume": "6"
        },
        "b0040": {
            "authors": [
                {
                    "first": "H. Martin",
                    "initial": "H.M.",
                    "last": "Vordermeier"
                },
                {
                    "first": "Shelley G.",
                    "initial": "S.G.",
                    "last": "Rhodes"
                },
                {
                    "first": "Gillian",
                    "initial": "G.",
                    "last": "Dean"
                },
                {
                    "first": "Nilu",
                    "initial": "N.",
                    "last": "Goonetilleke"
                },
                {
                    "first": "Kris",
                    "initial": "K.",
                    "last": "Huygen"
                },
                {
                    "first": "Adrian V.S.",
                    "initial": "A.V.S.",
                    "last": "Hill"
                },
                {
                    "first": "R. Glyn",
                    "initial": "R.G.",
                    "last": "Hewinson"
                },
                {
                    "first": "Sarah C.",
                    "initial": "S.C.",
                    "last": "Gilbert"
                }
            ],
            "doi": "10.1111/j.1365-2567.2004.01903.x",
            "firstpage": "461",
            "issn": "00192805",
            "lastpage": "470",
            "pmid": "15196215",
            "pub_year": 2004,
            "title": "Cellular immune responses induced in cattle by heterologous prime-boost vaccination using recombinant viruses and bacille Calmette-Gu\u00e9rin",
            "volume": "112"
        },
        "b0045": {
            "authors": [
                {
                    "first": "H. Martin",
                    "initial": "H.M.",
                    "last": "Vordermeier"
                },
                {
                    "first": "Kris",
                    "initial": "K.",
                    "last": "Huygen"
                },
                {
                    "first": "Mahavir",
                    "initial": "M.",
                    "last": "Singh"
                },
                {
                    "first": "R. Glyn",
                    "initial": "R.G.",
                    "last": "Hewinson"
                },
                {
                    "first": "Zhou",
                    "initial": "Z.",
                    "last": "Xing"
                }
            ],
            "doi": "10.1128/IAI.74.2.1416-1418.2006",
            "firstpage": "1416",
            "issn": "00199567",
            "lastpage": "1418",
            "pmid": "16428796",
            "pub_year": 2006,
            "title": "Immune responses induced in cattle by vaccination with a recombinant adenovirus expressing mycobacterial antigen 85A and Mycobacterium bovis BCG",
            "volume": "74"
        },
        "b0050": {
            "authors": [
                {
                    "first": "H.",
                    "initial": "H.",
                    "last": "McShane"
                },
                {
                    "first": "R.",
                    "initial": "R.",
                    "last": "Brookes"
                },
                {
                    "first": "S. C.",
                    "initial": "S.C.",
                    "last": "Gilbert"
                },
                {
                    "first": "A. V.S.",
                    "initial": "A.V.S.",
                    "last": "Hill"
                }
            ],
            "doi": "10.1128/IAI.69.2.681-686.2001",
            "firstpage": "681",
            "issn": "00199567",
            "lastpage": "686",
            "pmid": "11159955",
            "pub_year": 2001,
            "title": "Enhanced immunogenicity of CD4+ T-cell responses and protective efficacy of a DNA-modified vaccinia virus ankara prime-boost vaccination regimen for murine tuberculosis",
            "volume": "69"
        },
        "b0055": {
            "authors": [
                {
                    "first": "Michele D.",
                    "initial": "M.D.",
                    "last": "Tameris"
                },
                {
                    "first": "Mark",
                    "initial": "M.",
                    "last": "Hatherill"
                },
                {
                    "first": "Bernard S.",
                    "initial": "B.S.",
                    "last": "Landry"
                },
                {
                    "first": "Thomas J.",
                    "initial": "T.J.",
                    "last": "Scriba"
                },
                {
                    "first": "Margaret Ann",
                    "initial": "M.A.",
                    "last": "Snowden"
                },
                {
                    "first": "Stephen",
                    "initial": "S.",
                    "last": "Lockhart"
                },
                {
                    "first": "Jacqueline E.",
                    "initial": "J.E.",
                    "last": "Shea"
                },
                {
                    "first": "J. Bruce",
                    "initial": "J.B.",
                    "last": "McClain"
                },
                {
                    "first": "Gregory D.",
                    "initial": "G.D.",
                    "last": "Hussey"
                },
                {
                    "first": "Willem A.",
                    "initial": "W.A.",
                    "last": "Hanekom"
                },
                {
                    "first": "Hassan",
                    "initial": "H.",
                    "last": "Mahomed"
                },
                {
                    "first": "Helen",
                    "initial": "H.",
                    "last": "McShane"
                }
            ],
            "doi": "10.1016/S0140-6736(13)60177-4",
            "firstpage": "1021",
            "issn": "01406736",
            "lastpage": "1028",
            "pmid": "23391465",
            "pub_year": 2013,
            "title": "Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: A randomised, placebo-controlled phase 2b trial",
            "volume": "381"
        },
        "b0060": {
            "authors": [
                {
                    "first": "Caroline",
                    "initial": "C.",
                    "last": "Ogwang"
                },
                {
                    "first": "Domtila",
                    "initial": "D.",
                    "last": "Kimani"
                },
                {
                    "first": "Nick J.",
                    "initial": "N.J.",
                    "last": "Edwards"
                },
                {
                    "first": "Rachel",
                    "initial": "R.",
                    "last": "Roberts"
                },
                {
                    "first": "Jedidah",
                    "initial": "J.",
                    "last": "Mwacharo"
                },
                {
                    "first": "Georgina",
                    "initial": "G.",
                    "last": "Bowyer"
                },
                {
                    "first": "Carly",
                    "initial": "C.",
                    "last": "Bliss"
                },
                {
                    "first": "Susanne H.",
                    "initial": "S.H.",
                    "last": "Hodgson"
                },
                {
                    "first": "Patricia",
                    "initial": "P.",
                    "last": "Njuguna"
                },
                {
                    "first": "Nicola K.",
                    "initial": "N.K.",
                    "last": "Viebig"
                },
                {
                    "first": "Alfredo",
                    "initial": "A.",
                    "last": "Nicosia"
                },
                {
                    "first": "Evelyn",
                    "initial": "E.",
                    "last": "Gitau"
                },
                {
                    "first": "Sandy",
                    "initial": "S.",
                    "last": "Douglas"
                },
                {
                    "first": "Joe",
                    "initial": "J.",
                    "last": "Illingworth"
                },
                {
                    "first": "Kevin",
                    "initial": "K.",
                    "last": "Marsh"
                },
                {
                    "first": "Alison",
                    "initial": "A.",
                    "last": "Lawrie"
                },
                {
                    "first": "Egeruan B.",
                    "initial": "E.B.",
                    "last": "Imoukhuede"
                },
                {
                    "first": "Katie",
                    "initial": "K.",
                    "last": "Ewer"
                },
                {
                    "first": "Britta C.",
                    "initial": "B.C.",
                    "last": "Urban"
                },
                {
                    "first": "Adrian V.S.",
                    "initial": "A.V.S.",
                    "last": "Hill"
                },
                {
                    "first": "Philip",
                    "initial": "P.",
                    "last": "Bejon"
                },
                {
                    "first": "Odile",
                    "initial": "O.",
                    "last": "Leroy"
                },
                {
                    "first": "Badara",
                    "initial": "B.",
                    "last": "Cisse"
                },
                {
                    "first": "Sodiomon",
                    "initial": "S.",
                    "last": "Sirima"
                },
                {
                    "first": "Kalifa",
                    "initial": "K.",
                    "last": "Bojang"
                },
                {
                    "first": "Georgina",
                    "initial": "G.",
                    "last": "Murphy"
                },
                {
                    "first": "Henry",
                    "initial": "H.",
                    "last": "Karanja"
                },
                {
                    "first": "Lydiah",
                    "initial": "L.",
                    "last": "Nyamako"
                },
                {
                    "first": "Simone",
                    "initial": "S.",
                    "last": "De Cassan"
                },
                {
                    "first": "Ken",
                    "initial": "K.",
                    "last": "Awuondo"
                },
                {
                    "first": "Dominic",
                    "initial": "D.",
                    "last": "Kwiatkowski"
                },
                {
                    "first": "Kirk",
                    "initial": "K.",
                    "last": "Rockett"
                },
                {
                    "first": "Sarah",
                    "initial": "S.",
                    "last": "Gilbert"
                },
                {
                    "first": "Nicholas",
                    "initial": "N.",
                    "last": "Anagnostou"
                },
                {
                    "first": "Peninah",
                    "initial": "P.",
                    "last": "Soipei"
                },
                {
                    "first": "Judy",
                    "initial": "J.",
                    "last": "Peshu"
                },
                {
                    "first": "Ines",
                    "initial": "I.",
                    "last": "Petersen"
                },
                {
                    "first": "Brian",
                    "initial": "B.",
                    "last": "Mutinda"
                },
                {
                    "first": "Naomi",
                    "initial": "N.",
                    "last": "Waithira"
                },
                {
                    "first": "Mahfudh",
                    "initial": "M.",
                    "last": "Bashraheil"
                },
                {
                    "first": "Jimmy",
                    "initial": "J.",
                    "last": "Shangala"
                },
                {
                    "first": "Sarah",
                    "initial": "S.",
                    "last": "Moyle"
                },
                {
                    "first": "Eleanor",
                    "initial": "E.",
                    "last": "Berrie"
                },
                {
                    "first": "Geoffrey",
                    "initial": "G.",
                    "last": "Targett"
                },
                {
                    "first": "Mahamadou",
                    "initial": "M.",
                    "last": "Thera"
                },
                {
                    "first": "Paul",
                    "initial": "P.",
                    "last": "Milligan"
                },
                {
                    "first": "Bernhards",
                    "initial": "B.",
                    "last": "Ogutu"
                }
            ],
            "doi": "10.1126/scitranslmed.aaa2373",
            "issn": "19466234",
            "pmid": "25947165",
            "pub_year": 2015,
            "title": "Prime-boost vaccination with chimpanzee adenovirus and modified vaccinia Ankara encoding TRAP provides partial protection against Plasmodium falciparum infection in Kenyan adults",
            "volume": "7"
        },
        "b0065": null,
        "b0070": {
            "authors": [
                {
                    "first": "Sharon",
                    "initial": "S.",
                    "last": "Sheehan"
                },
                {
                    "first": "Stephanie A.",
                    "initial": "S.A.",
                    "last": "Harris"
                },
                {
                    "first": "Iman",
                    "initial": "I.",
                    "last": "Satti"
                },
                {
                    "first": "David A.",
                    "initial": "D.A.",
                    "last": "Hokey"
                },
                {
                    "first": "Veerabadran",
                    "initial": "V.",
                    "last": "Dheenadhayalan"
                },
                {
                    "first": "Lisa",
                    "initial": "L.",
                    "last": "Stockdale"
                },
                {
                    "first": "Zita Rose",
                    "initial": "Z.R.",
                    "last": "Manjaly Thomas"
                },
                {
                    "first": "Alice",
                    "initial": "A.",
                    "last": "Minhinnick"
                },
                {
                    "first": "Morven",
                    "initial": "M.",
                    "last": "Wilkie"
                },
                {
                    "first": "Samantha",
                    "initial": "S.",
                    "last": "Vermaak"
                },
                {
                    "first": "Joel",
                    "initial": "J.",
                    "last": "Meyer"
                },
                {
                    "first": "Matthew K.",
                    "initial": "M.K.",
                    "last": "O'Shea"
                },
                {
                    "first": "Maria Grazia",
                    "initial": "M.G.",
                    "last": "Pau"
                },
                {
                    "first": "Isabella",
                    "initial": "I.",
                    "last": "Versteege"
                },
                {
                    "first": "Macaya",
                    "initial": "M.",
                    "last": "Douoguih"
                },
                {
                    "first": "Jenny",
                    "initial": "J.",
                    "last": "Hendriks"
                },
                {
                    "first": "Jerald",
                    "initial": "J.",
                    "last": "Sadoff"
                },
                {
                    "first": "Bernard",
                    "initial": "B.",
                    "last": "Landry"
                },
                {
                    "first": "Paul",
                    "initial": "P.",
                    "last": "Moss"
                },
                {
                    "first": "Helen",
                    "initial": "H.",
                    "last": "McShane"
                }
            ],
            "doi": "10.1371/journal.pone.0141687",
            "issn": "19326203",
            "pmid": "26529238",
            "pub_year": 2015,
            "title": "A phase I, open-label trial, evaluating the safety and immunogenicity of candidate tuberculosis vaccines AERAS-402 and MVA85A, administered by prime-boost regime in BCG-vaccinated healthy adults",
            "volume": "10"
        },
        "b0075": {
            "authors": [
                {
                    "first": "O.",
                    "initial": "O.",
                    "last": "Van Der Meeren"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Hatherill"
                },
                {
                    "first": "V.",
                    "initial": "V.",
                    "last": "Nduba"
                },
                {
                    "first": "R. J.",
                    "initial": "R.J.",
                    "last": "Wilkinson"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Muyoyeta"
                },
                {
                    "first": "E.",
                    "initial": "E.",
                    "last": "Van Brakel"
                },
                {
                    "first": "H. M.",
                    "initial": "H.M.",
                    "last": "Ayles"
                },
                {
                    "first": "G.",
                    "initial": "G.",
                    "last": "Henostroza"
                },
                {
                    "first": "F.",
                    "initial": "F.",
                    "last": "Thienemann"
                },
                {
                    "first": "T. J.",
                    "initial": "T.J.",
                    "last": "Scriba"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Diacon"
                },
                {
                    "first": "G. L.",
                    "initial": "G.L.",
                    "last": "Blatner"
                },
                {
                    "first": "M. A.",
                    "initial": "M.A.",
                    "last": "Demoitie"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Tameris"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Malahleha"
                },
                {
                    "first": "J. C.",
                    "initial": "J.C.",
                    "last": "Innes"
                },
                {
                    "first": "E.",
                    "initial": "E.",
                    "last": "Hellstrom"
                },
                {
                    "first": "N.",
                    "initial": "N.",
                    "last": "Martinson"
                },
                {
                    "first": "T.",
                    "initial": "T.",
                    "last": "Singh"
                },
                {
                    "first": "E. J.",
                    "initial": "E.J.",
                    "last": "Akite"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Khatoon Azam"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Bollaerts"
                },
                {
                    "first": "A. M.",
                    "initial": "A.M.",
                    "last": "Ginsberg"
                },
                {
                    "first": "T. G.",
                    "initial": "T.G.",
                    "last": "Evans"
                },
                {
                    "first": "P.",
                    "initial": "P.",
                    "last": "Gillard"
                },
                {
                    "first": "D. R.",
                    "initial": "D.R.",
                    "last": "Tait"
                }
            ],
            "doi": "10.1056/NEJMoa1803484",
            "firstpage": "1621",
            "issn": "00284793",
            "lastpage": "1634",
            "pmid": "30280651",
            "pub_year": 2018,
            "title": "Phase 2b controlled trial of M72/AS01E vaccine to prevent tuberculosis",
            "volume": "379"
        },
        "b0080": {
            "authors": [
                {
                    "first": "Matthew D.J.",
                    "initial": "M.D.J.",
                    "last": "Dicks"
                },
                {
                    "first": "Alexandra J.",
                    "initial": "A.J.",
                    "last": "Spencer"
                },
                {
                    "first": "Nick J.",
                    "initial": "N.J.",
                    "last": "Edwards"
                },
                {
                    "first": "G\u00f6ran",
                    "initial": "G.",
                    "last": "Wadell"
                },
                {
                    "first": "Kalifa",
                    "initial": "K.",
                    "last": "Bojang"
                },
                {
                    "first": "Sarah C.",
                    "initial": "S.C.",
                    "last": "Gilbert"
                },
                {
                    "first": "Adrian V.S.",
                    "initial": "A.V.S.",
                    "last": "Hill"
                },
                {
                    "first": "Matthew G.",
                    "initial": "M.G.",
                    "last": "Cottingham"
                }
            ],
            "doi": "10.1371/journal.pone.0040385",
            "issn": "19326203",
            "pmid": "22808149",
            "pub_year": 2012,
            "title": "A novel chimpanzee adenovirus vector with low human seroprevalence: Improved systems for vector derivation and comparative immunogenicity",
            "volume": "7"
        },
        "b0085": {
            "authors": [
                {
                    "first": "Richard D.",
                    "initial": "R.D.",
                    "last": "Antrobus"
                },
                {
                    "first": "Lynda",
                    "initial": "L.",
                    "last": "Coughlan"
                },
                {
                    "first": "Tamara K.",
                    "initial": "T.K.",
                    "last": "Berthoud"
                },
                {
                    "first": "Matthew D.",
                    "initial": "M.D.",
                    "last": "Dicks"
                },
                {
                    "first": "Adrian V.S.",
                    "initial": "A.V.S.",
                    "last": "Hill"
                },
                {
                    "first": "Teresa",
                    "initial": "T.",
                    "last": "Lambe"
                },
                {
                    "first": "Sarah C.",
                    "initial": "S.C.",
                    "last": "Gilbert"
                }
            ],
            "doi": "10.1038/mt.2013.284",
            "firstpage": "668",
            "issn": "15250016",
            "lastpage": "674",
            "pmid": "24374965",
            "pub_year": 2014,
            "title": "Clinical assessment of a novel recombinant simian adenovirus ChAdOx1 as a vectored vaccine expressing conserved influenza a antigens",
            "volume": "22"
        },
        "b0090": {
            "authors": [
                {
                    "first": "E.",
                    "initial": "E.",
                    "last": "Stylianou"
                },
                {
                    "first": "K. L.",
                    "initial": "K.L.",
                    "last": "Griffiths"
                },
                {
                    "first": "H. C.",
                    "initial": "H.C.",
                    "last": "Poyntz"
                },
                {
                    "first": "R.",
                    "initial": "R.",
                    "last": "Harrington-Kandt"
                },
                {
                    "first": "M. D.",
                    "initial": "M.D.",
                    "last": "Dicks"
                },
                {
                    "first": "L.",
                    "initial": "L.",
                    "last": "Stockdale"
                },
                {
                    "first": "G.",
                    "initial": "G.",
                    "last": "Betts"
                },
                {
                    "first": "H.",
                    "initial": "H.",
                    "last": "McShane"
                }
            ],
            "doi": "10.1016/j.vaccine.2015.10.017",
            "firstpage": "6800",
            "issn": "0264410X",
            "lastpage": "6808",
            "pmid": "26478198",
            "pub_year": 2015,
            "title": "Improvement of BCG protective efficacy with a novel chimpanzee adenovirus and a modified vaccinia Ankara virus both expressing Ag85A",
            "volume": "33"
        },
        "b0095": {
            "authors": [
                {
                    "first": "Willem A.",
                    "initial": "W.A.",
                    "last": "Hanekom"
                },
                {
                    "first": "Jane",
                    "initial": "J.",
                    "last": "Hughes"
                },
                {
                    "first": "Maushumi",
                    "initial": "M.",
                    "last": "Mavinkurve"
                },
                {
                    "first": "Megan",
                    "initial": "M.",
                    "last": "Mendillo"
                },
                {
                    "first": "Marcia",
                    "initial": "M.",
                    "last": "Watkins"
                },
                {
                    "first": "Hoyam",
                    "initial": "H.",
                    "last": "Gamieldien"
                },
                {
                    "first": "Sebastian J.",
                    "initial": "S.J.",
                    "last": "Gelderbloem"
                },
                {
                    "first": "Mzwandile",
                    "initial": "M.",
                    "last": "Sidibana"
                },
                {
                    "first": "Nazma",
                    "initial": "N.",
                    "last": "Mansoor"
                },
                {
                    "first": "Virginia",
                    "initial": "V.",
                    "last": "Davids"
                },
                {
                    "first": "Rose Ann",
                    "initial": "R.A.",
                    "last": "Murray"
                },
                {
                    "first": "Anthony",
                    "initial": "A.",
                    "last": "Hawkridge"
                },
                {
                    "first": "Patrick A.J.",
                    "initial": "P.A.J.",
                    "last": "Haslett"
                },
                {
                    "first": "Stanley",
                    "initial": "S.",
                    "last": "Ress"
                },
                {
                    "first": "Gregory D.",
                    "initial": "G.D.",
                    "last": "Hussey"
                },
                {
                    "first": "Gilla",
                    "initial": "G.",
                    "last": "Kaplan"
                }
            ],
            "doi": "10.1016/j.jim.2004.06.010",
            "firstpage": "185",
            "issn": "00221759",
            "lastpage": "195",
            "pmid": "15345316",
            "pub_year": 2004,
            "title": "Novel application of a whole blood intracellular cytokine detection assay to quantitate specific T-cell frequency in field studies",
            "volume": "291"
        },
        "b0100": {
            "authors": [
                {
                    "first": "Joel",
                    "initial": "J.",
                    "last": "Meyer"
                },
                {
                    "first": "Stephanie A.",
                    "initial": "S.A.",
                    "last": "Harris"
                },
                {
                    "first": "Iman",
                    "initial": "I.",
                    "last": "Satti"
                },
                {
                    "first": "Ian D.",
                    "initial": "I.D.",
                    "last": "Poulton"
                },
                {
                    "first": "Hazel C.",
                    "initial": "H.C.",
                    "last": "Poyntz"
                },
                {
                    "first": "Rachel",
                    "initial": "R.",
                    "last": "Tanner"
                },
                {
                    "first": "Rosalind",
                    "initial": "R.",
                    "last": "Rowland"
                },
                {
                    "first": "Kristin L.",
                    "initial": "K.L.",
                    "last": "Griffiths"
                },
                {
                    "first": "Helen A.",
                    "initial": "H.A.",
                    "last": "Fletcher"
                },
                {
                    "first": "Helen",
                    "initial": "H.",
                    "last": "McShane"
                }
            ],
            "doi": "10.1016/j.vaccine.2012.12.042",
            "firstpage": "1026",
            "issn": "0264410X",
            "lastpage": "1033",
            "pmid": "23266342",
            "pub_year": 2013,
            "title": "Comparing the safety and immunogenicity of a candidate TB vaccine MVA85A administered by intramuscular and intradermal delivery",
            "volume": "31"
        },
        "b0105": {
            "authors": [
                {
                    "first": "Emmanuelle",
                    "initial": "E.",
                    "last": "Jouanguy"
                },
                {
                    "first": "Fr\u00e9d\u00e9ric",
                    "initial": "F.",
                    "last": "Altare"
                },
                {
                    "first": "Salma",
                    "initial": "S.",
                    "last": "Lamhamedi"
                },
                {
                    "first": "Patrick",
                    "initial": "P.",
                    "last": "Revy"
                },
                {
                    "first": "Jean Fran\u00e7ois",
                    "initial": "J.F.",
                    "last": "Emile"
                },
                {
                    "first": "Melanie",
                    "initial": "M.",
                    "last": "Newport"
                },
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Levin"
                },
                {
                    "first": "St\u00e9phane",
                    "initial": "S.",
                    "last": "Blanche"
                },
                {
                    "first": "Eric",
                    "initial": "E.",
                    "last": "Seboun"
                },
                {
                    "first": "Alain",
                    "initial": "A.",
                    "last": "Fischer"
                },
                {
                    "first": "Jean Laurent",
                    "initial": "J.L.",
                    "last": "Casanova"
                }
            ],
            "firstpage": "1956",
            "issn": "00284793",
            "lastpage": "1961",
            "pmid": "8960475",
            "pub_year": 1996,
            "title": "Interferon-\u03b3-receptor deficiency in an infant with fatal bacille Calmette-Gu\u00e9rin infection",
            "volume": "335"
        },
        "b0110": {
            "authors": [
                {
                    "first": "M. J.",
                    "initial": "M.J.",
                    "last": "Newport"
                },
                {
                    "first": "C. M.",
                    "initial": "C.M.",
                    "last": "Huxley"
                },
                {
                    "first": "S.",
                    "initial": "S.",
                    "last": "Huston"
                },
                {
                    "first": "C. M.",
                    "initial": "C.M.",
                    "last": "Hawrylowicz"
                },
                {
                    "first": "B. A.",
                    "initial": "B.A.",
                    "last": "Oostra"
                },
                {
                    "first": "R.",
                    "initial": "R.",
                    "last": "Williamson"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Levin"
                }
            ],
            "doi": "10.1056/NEJM199612263352602",
            "firstpage": "1941",
            "issn": "00284793",
            "lastpage": "1949",
            "pmid": "8960473",
            "pub_year": 1996,
            "title": "A mutation in the interferon-\u03b3-receptor gene and susceptibility to mycobacterial infection",
            "volume": "335"
        },
        "b0115": {
            "authors": [
                {
                    "first": "Jo Anne L.",
                    "initial": "J.A.L.",
                    "last": "Flynn"
                },
                {
                    "first": "John",
                    "initial": "J.",
                    "last": "Chan"
                },
                {
                    "first": "Karla J.",
                    "initial": "K.J.",
                    "last": "Triebold"
                },
                {
                    "first": "Dyana K.",
                    "initial": "D.K.",
                    "last": "Dalton"
                },
                {
                    "first": "Timothy A.",
                    "initial": "T.A.",
                    "last": "Stewart"
                },
                {
                    "first": "Barry R.",
                    "initial": "B.R.",
                    "last": "Bloom"
                }
            ],
            "doi": "10.1084/jem.178.6.2249",
            "firstpage": "2249",
            "issn": "00221007",
            "lastpage": "2254",
            "pmid": "7504064",
            "pub_year": 1993,
            "title": "An essential role for interferon \u03b3 in resistance to mycobacterium tuberculosis infection",
            "volume": "178"
        },
        "b0120": {
            "authors": [
                {
                    "first": "Helen A.",
                    "initial": "H.A.",
                    "last": "Fletcher"
                },
                {
                    "first": "Margaret A.",
                    "initial": "M.A.",
                    "last": "Snowden"
                },
                {
                    "first": "Bernard",
                    "initial": "B.",
                    "last": "Landry"
                },
                {
                    "first": "Wasima",
                    "initial": "W.",
                    "last": "Rida"
                },
                {
                    "first": "Iman",
                    "initial": "I.",
                    "last": "Satti"
                },
                {
                    "first": "Stephanie A.",
                    "initial": "S.A.",
                    "last": "Harris"
                },
                {
                    "first": "Magali",
                    "initial": "M.",
                    "last": "Matsumiya"
                },
                {
                    "first": "Rachel",
                    "initial": "R.",
                    "last": "Tanner"
                },
                {
                    "first": "Matthew K.",
                    "initial": "M.K.",
                    "last": "Oshea"
                },
                {
                    "first": "Veerabadran",
                    "initial": "V.",
                    "last": "Dheenadhayalan"
                },
                {
                    "first": "Leah",
                    "initial": "L.",
                    "last": "Bogardus"
                },
                {
                    "first": "Lisa",
                    "initial": "L.",
                    "last": "Stockdale"
                },
                {
                    "first": "Leanne",
                    "initial": "L.",
                    "last": "Marsay"
                },
                {
                    "first": "Agnieszka",
                    "initial": "A.",
                    "last": "Chomka"
                },
                {
                    "first": "Rachel",
                    "initial": "R.",
                    "last": "Harrington-Kandt"
                },
                {
                    "first": "Zita Rose",
                    "initial": "Z.R.",
                    "last": "Manjaly-Thomas"
                },
                {
                    "first": "Vivek",
                    "initial": "V.",
                    "last": "Naranbhai"
                },
                {
                    "first": "Elena",
                    "initial": "E.",
                    "last": "Stylianou"
                },
                {
                    "first": "Fatoumatta",
                    "initial": "F.",
                    "last": "Darboe"
                },
                {
                    "first": "Adam",
                    "initial": "A.",
                    "last": "Penn-Nicholson"
                },
                {
                    "first": "Elisa",
                    "initial": "E.",
                    "last": "Nemes"
                },
                {
                    "first": "Mark",
                    "initial": "M.",
                    "last": "Hatheril"
                },
                {
                    "first": "Gregory",
                    "initial": "G.",
                    "last": "Hussey"
                },
                {
                    "first": "Hassan",
                    "initial": "H.",
                    "last": "Mahomed"
                },
                {
                    "first": "Michele",
                    "initial": "M.",
                    "last": "Tameris"
                },
                {
                    "first": "J. Bruce",
                    "initial": "J.B.",
                    "last": "McClain"
                },
                {
                    "first": "Thomas G.",
                    "initial": "T.G.",
                    "last": "Evans"
                },
                {
                    "first": "Willem A.",
                    "initial": "W.A.",
                    "last": "Hanekom"
                },
                {
                    "first": "Thomas J.",
                    "initial": "T.J.",
                    "last": "Scriba"
                },
                {
                    "first": "Helen",
                    "initial": "H.",
                    "last": "McShane"
                }
            ],
            "doi": "10.1038/ncomms11290",
            "issn": "20411723",
            "pmid": "27068708",
            "pub_year": 2016,
            "title": "T-cell activation is an immune correlate of risk in BCG vaccinated infants",
            "volume": "7"
        },
        "b0125": {
            "authors": [
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "Harris"
                },
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "Keane"
                }
            ],
            "doi": "10.1111/j.1365-2249.2010.04146.x",
            "firstpage": "1",
            "issn": "00099104",
            "lastpage": "9",
            "pmid": "20491796",
            "pub_year": 2010,
            "title": "How tumour necrosis factor blockers interfere with tuberculosis immunity",
            "volume": "161"
        },
        "b0130": {
            "authors": [
                {
                    "first": "Kendall A.",
                    "initial": "K.A.",
                    "last": "Smith"
                }
            ],
            "doi": "10.1126/science.3131876",
            "firstpage": "1169",
            "issn": "00368075",
            "lastpage": "1176",
            "pmid": "3131876",
            "pub_year": 1988,
            "title": "Interleukin-2: Inception, impact, and implications",
            "volume": "240"
        },
        "b0135": {
            "authors": [
                {
                    "first": "Shabaana A.",
                    "initial": "S.A.",
                    "last": "Khader"
                },
                {
                    "first": "Guy K.",
                    "initial": "G.K.",
                    "last": "Bell"
                },
                {
                    "first": "John E.",
                    "initial": "J.E.",
                    "last": "Pearl"
                },
                {
                    "first": "Jeffrey J.",
                    "initial": "J.J.",
                    "last": "Fountain"
                },
                {
                    "first": "Javier",
                    "initial": "J.",
                    "last": "Rangel-Moreno"
                },
                {
                    "first": "Garth E.",
                    "initial": "G.E.",
                    "last": "Cilley"
                },
                {
                    "first": "Fang",
                    "initial": "F.",
                    "last": "Shen"
                },
                {
                    "first": "Sheri M.",
                    "initial": "S.M.",
                    "last": "Eaton"
                },
                {
                    "first": "Sarah L.",
                    "initial": "S.L.",
                    "last": "Gaffen"
                },
                {
                    "first": "Susan L.",
                    "initial": "S.L.",
                    "last": "Swain"
                },
                {
                    "first": "Richard M.",
                    "initial": "R.M.",
                    "last": "Locksley"
                },
                {
                    "first": "Laura",
                    "initial": "L.",
                    "last": "Haynes"
                },
                {
                    "first": "Troy D.",
                    "initial": "T.D.",
                    "last": "Randall"
                },
                {
                    "first": "Andrea M.",
                    "initial": "A.M.",
                    "last": "Cooper"
                }
            ],
            "doi": "10.1038/ni1449",
            "firstpage": "369",
            "issn": "15292908",
            "lastpage": "377",
            "pmid": "17351619",
            "pub_year": 2007,
            "title": "IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge",
            "volume": "8"
        },
        "b0140": {
            "authors": [
                {
                    "first": "Subash",
                    "initial": "S.",
                    "last": "Babu"
                },
                {
                    "first": "Sajid Q.",
                    "initial": "S.Q.",
                    "last": "Bhat"
                },
                {
                    "first": "N.",
                    "initial": "N.",
                    "last": "Pavan Kumar"
                },
                {
                    "first": "V.",
                    "initial": "V.",
                    "last": "Kumaraswami"
                },
                {
                    "first": "Thomas B.",
                    "initial": "T.B.",
                    "last": "Nutman"
                }
            ],
            "doi": "10.1086/648735",
            "firstpage": "20",
            "issn": "00221899",
            "lastpage": "31",
            "pmid": "19929695",
            "pub_year": 2010,
            "title": "Regulatory T cells modulate Th17 responses in patients with positive tuberculin skin test results",
            "volume": "201"
        },
        "b0145": {
            "authors": [
                {
                    "first": "Deborah A.",
                    "initial": "D.A.",
                    "last": "Lewinsohn"
                },
                {
                    "first": "Amy S.",
                    "initial": "A.S.",
                    "last": "Heinzel"
                },
                {
                    "first": "James M.",
                    "initial": "J.M.",
                    "last": "Gardner"
                },
                {
                    "first": "Liqing",
                    "initial": "L.",
                    "last": "Zhu"
                },
                {
                    "first": "Mark R.",
                    "initial": "M.R.",
                    "last": "Alderson"
                },
                {
                    "first": "David M.",
                    "initial": "D.M.",
                    "last": "Lewinsohn"
                }
            ],
            "doi": "10.1164/rccm.200306-837OC",
            "firstpage": "1346",
            "issn": "1073449X",
            "lastpage": "1352",
            "pmid": "12969871",
            "pub_year": 2003,
            "title": "Mycobacterium tuberculosis-specific CD8+ T Cells Preferentially Recognize Heavily Infected Cells",
            "volume": "168"
        },
        "b0150": {
            "authors": [
                {
                    "first": "Crystal Y.",
                    "initial": "C.Y.",
                    "last": "Chen"
                },
                {
                    "first": "Dan",
                    "initial": "D.",
                    "last": "Huang"
                },
                {
                    "first": "Richard C.",
                    "initial": "R.C.",
                    "last": "Wang"
                },
                {
                    "first": "Ling",
                    "initial": "L.",
                    "last": "Shen"
                },
                {
                    "first": "Gucheng",
                    "initial": "G.",
                    "last": "Zeng"
                },
                {
                    "first": "Shuyun",
                    "initial": "S.",
                    "last": "Yao"
                },
                {
                    "first": "Yun",
                    "initial": "Y.",
                    "last": "Shen"
                },
                {
                    "first": "Lisa",
                    "initial": "L.",
                    "last": "Halliday"
                },
                {
                    "first": "Jeff",
                    "initial": "J.",
                    "last": "Fortman"
                },
                {
                    "first": "Milton",
                    "initial": "M.",
                    "last": "McAllister"
                },
                {
                    "first": "Jim",
                    "initial": "J.",
                    "last": "Estep"
                },
                {
                    "first": "Robert",
                    "initial": "R.",
                    "last": "Hunt"
                },
                {
                    "first": "Daphne",
                    "initial": "D.",
                    "last": "Vasconcelos"
                },
                {
                    "first": "George",
                    "initial": "G.",
                    "last": "Du"
                },
                {
                    "first": "Steven A.",
                    "initial": "S.A.",
                    "last": "Porcelli"
                },
                {
                    "first": "Michelle H.",
                    "initial": "M.H.",
                    "last": "Larsen"
                },
                {
                    "first": "William R.",
                    "initial": "W.R.",
                    "last": "Jacobs"
                },
                {
                    "first": "Barton F.",
                    "initial": "B.F.",
                    "last": "Haynes"
                },
                {
                    "first": "Norman L.",
                    "initial": "N.L.",
                    "last": "Letvin"
                },
                {
                    "first": "Zheng W.",
                    "initial": "Z.W.",
                    "last": "Chen"
                }
            ],
            "doi": "10.1371/journal.ppat.1000392",
            "issn": "15537366",
            "pmid": "19381260",
            "pub_year": 2009,
            "title": "A critical role for CD8 T cells in a nonhuman primate model of tuberculosis",
            "volume": "5"
        },
        "b0155": {
            "authors": [
                {
                    "first": "Alexandra O.",
                    "initial": "A.O.",
                    "last": "Sousa"
                },
                {
                    "first": "Richard J.",
                    "initial": "R.J.",
                    "last": "Mazzaccaro"
                },
                {
                    "first": "Robert G.",
                    "initial": "R.G.",
                    "last": "Russell"
                },
                {
                    "first": "Francis K.",
                    "initial": "F.K.",
                    "last": "Lee"
                },
                {
                    "first": "Oliver C.",
                    "initial": "O.C.",
                    "last": "Turner"
                },
                {
                    "first": "Seokmann",
                    "initial": "S.",
                    "last": "Hong"
                },
                {
                    "first": "Luc",
                    "initial": "L.",
                    "last": "Van Kaer"
                },
                {
                    "first": "Barry R.",
                    "initial": "B.R.",
                    "last": "Bloom"
                }
            ],
            "doi": "10.1073/pnas.97.8.4204",
            "firstpage": "4204",
            "issn": "00278424",
            "lastpage": "4208",
            "pmid": "10760288",
            "pub_year": 2000,
            "title": "Relative contributions of distinct MHC class I-dependent cell populations in protection to tuberculosis infection in mice",
            "volume": "97"
        },
        "b0160": {
            "authors": [
                {
                    "first": "Iain D.",
                    "initial": "I.D.",
                    "last": "Milligan"
                },
                {
                    "first": "Malick M.",
                    "initial": "M.M.",
                    "last": "Gibani"
                },
                {
                    "first": "Richard",
                    "initial": "R.",
                    "last": "Sewell"
                },
                {
                    "first": "Elizabeth A.",
                    "initial": "E.A.",
                    "last": "Clutterbuck"
                },
                {
                    "first": "Danielle",
                    "initial": "D.",
                    "last": "Campbell"
                },
                {
                    "first": "Emma",
                    "initial": "E.",
                    "last": "Plested"
                },
                {
                    "first": "Elizabeth",
                    "initial": "E.",
                    "last": "Nuthall"
                },
                {
                    "first": "Merryn",
                    "initial": "M.",
                    "last": "Voysey"
                },
                {
                    "first": "Laura",
                    "initial": "L.",
                    "last": "Silva-Reyes"
                },
                {
                    "first": "M. Juliana",
                    "initial": "M.J.",
                    "last": "McElrath"
                },
                {
                    "first": "Stephen C.",
                    "initial": "S.C.",
                    "last": "De Rosa"
                },
                {
                    "first": "Nicole",
                    "initial": "N.",
                    "last": "Frahm"
                },
                {
                    "first": "Kristen W.",
                    "initial": "K.W.",
                    "last": "Cohen"
                },
                {
                    "first": "Georgi",
                    "initial": "G.",
                    "last": "Shukarev"
                },
                {
                    "first": "Nicola",
                    "initial": "N.",
                    "last": "Orzabal"
                },
                {
                    "first": "Wilbert",
                    "initial": "W.",
                    "last": "Van Duijnhoven"
                },
                {
                    "first": "Carla",
                    "initial": "C.",
                    "last": "Truyers"
                },
                {
                    "first": "Nora",
                    "initial": "N.",
                    "last": "Bachmayer"
                },
                {
                    "first": "Daniel",
                    "initial": "D.",
                    "last": "Splinter"
                },
                {
                    "first": "Nathaly",
                    "initial": "N.",
                    "last": "Samy"
                },
                {
                    "first": "Maria Grazia",
                    "initial": "M.G.",
                    "last": "Pau"
                },
                {
                    "first": "Hanneke",
                    "initial": "H.",
                    "last": "Schuitemaker"
                },
                {
                    "first": "Kerstin",
                    "initial": "K.",
                    "last": "Luhn"
                },
                {
                    "first": "Benoit",
                    "initial": "B.",
                    "last": "Callendret"
                },
                {
                    "first": "Johan",
                    "initial": "J.",
                    "last": "Van Hoof"
                },
                {
                    "first": "Macaya",
                    "initial": "M.",
                    "last": "Douoguih"
                },
                {
                    "first": "Katie",
                    "initial": "K.",
                    "last": "Ewer"
                },
                {
                    "first": "Brian",
                    "initial": "B.",
                    "last": "Angus"
                },
                {
                    "first": "Andrew J.",
                    "initial": "A.J.",
                    "last": "Pollard"
                },
                {
                    "first": "Matthew D.",
                    "initial": "M.D.",
                    "last": "Snape"
                }
            ],
            "doi": "10.1001/jama.2016.4218",
            "firstpage": "1610",
            "issn": "00987484",
            "lastpage": "1623",
            "pmid": "27092831",
            "pub_year": 2016,
            "title": "Safety and immunogenicity of novel adenovirus type 26-and modified vaccinia Ankara-vectored Ebola vaccines: A randomized clinical trial",
            "volume": "315"
        },
        "b0165": {
            "authors": [
                {
                    "first": "Susanne H.",
                    "initial": "S.H.",
                    "last": "Sheehy"
                },
                {
                    "first": "Christopher J.A.",
                    "initial": "C.J.A.",
                    "last": "Duncan"
                },
                {
                    "first": "Sean C.",
                    "initial": "S.C.",
                    "last": "Elias"
                },
                {
                    "first": "Sumi",
                    "initial": "S.",
                    "last": "Biswas"
                },
                {
                    "first": "Katharine A.",
                    "initial": "K.A.",
                    "last": "Collins"
                },
                {
                    "first": "Geraldine A.",
                    "initial": "G.A.",
                    "last": "O'Hara"
                },
                {
                    "first": "Fenella D.",
                    "initial": "F.D.",
                    "last": "Halstead"
                },
                {
                    "first": "Katie J.",
                    "initial": "K.J.",
                    "last": "Ewer"
                },
                {
                    "first": "Tabitha",
                    "initial": "T.",
                    "last": "Mahungu"
                },
                {
                    "first": "Alexandra J.",
                    "initial": "A.J.",
                    "last": "Spencer"
                },
                {
                    "first": "Kazutoyo",
                    "initial": "K.",
                    "last": "Miura"
                },
                {
                    "first": "Ian D.",
                    "initial": "I.D.",
                    "last": "Poulton"
                },
                {
                    "first": "Matthew D.J.",
                    "initial": "M.D.J.",
                    "last": "Dicks"
                },
                {
                    "first": "Nick J.",
                    "initial": "N.J.",
                    "last": "Edwards"
                },
                {
                    "first": "Eleanor",
                    "initial": "E.",
                    "last": "Berrie"
                },
                {
                    "first": "Sarah",
                    "initial": "S.",
                    "last": "Moyle"
                },
                {
                    "first": "Stefano",
                    "initial": "S.",
                    "last": "Colloca"
                },
                {
                    "first": "Riccardo",
                    "initial": "R.",
                    "last": "Cortese"
                },
                {
                    "first": "Katherine",
                    "initial": "K.",
                    "last": "Gantlett"
                },
                {
                    "first": "Carole A.",
                    "initial": "C.A.",
                    "last": "Long"
                },
                {
                    "first": "Alison M.",
                    "initial": "A.M.",
                    "last": "Lawrie"
                },
                {
                    "first": "Sarah C.",
                    "initial": "S.C.",
                    "last": "Gilbert"
                },
                {
                    "first": "Tom",
                    "initial": "T.",
                    "last": "Doherty"
                },
                {
                    "first": "Alfredo",
                    "initial": "A.",
                    "last": "Nicosia"
                },
                {
                    "first": "Adrian V.S.",
                    "initial": "A.V.S.",
                    "last": "Hill"
                },
                {
                    "first": "Simon J.",
                    "initial": "S.J.",
                    "last": "Draper"
                }
            ],
            "doi": "10.1371/journal.pone.0031208",
            "issn": "19326203",
            "pmid": "22363582",
            "pub_year": 2012,
            "title": "Phase ia clinical evaluation of the safety and immunogenicity of the Plasmodium falciparum blood-stage antigen AMA1 in ChAd63 and MVA vaccine vectors",
            "volume": "7"
        },
        "b0170": {
            "authors": [
                {
                    "first": "K.",
                    "initial": "K.",
                    "last": "Ewer"
                },
                {
                    "first": "T.",
                    "initial": "T.",
                    "last": "Rampling"
                },
                {
                    "first": "N.",
                    "initial": "N.",
                    "last": "Venkatraman"
                },
                {
                    "first": "G.",
                    "initial": "G.",
                    "last": "Bowyer"
                },
                {
                    "first": "D.",
                    "initial": "D.",
                    "last": "Wright"
                },
                {
                    "first": "T.",
                    "initial": "T.",
                    "last": "Lambe"
                },
                {
                    "first": "E. B.",
                    "initial": "E.B.",
                    "last": "Imoukhuede"
                },
                {
                    "first": "R.",
                    "initial": "R.",
                    "last": "Payne"
                },
                {
                    "first": "S. K.",
                    "initial": "S.K.",
                    "last": "Fehling"
                },
                {
                    "first": "T.",
                    "initial": "T.",
                    "last": "Strecker"
                },
                {
                    "first": "N.",
                    "initial": "N.",
                    "last": "Biedenkopf"
                },
                {
                    "first": "V.",
                    "initial": "V.",
                    "last": "Kr\u00e4hling"
                },
                {
                    "first": "C. M.",
                    "initial": "C.M.",
                    "last": "Tully"
                },
                {
                    "first": "N. J.",
                    "initial": "N.J.",
                    "last": "Edwards"
                },
                {
                    "first": "E. M.",
                    "initial": "E.M.",
                    "last": "Bentley"
                },
                {
                    "first": "D.",
                    "initial": "D.",
                    "last": "Samuel"
                },
                {
                    "first": "G.",
                    "initial": "G.",
                    "last": "Labb\u00e9"
                },
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "Jin"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Gibani"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Minhinnick"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Wilkie"
                },
                {
                    "first": "I.",
                    "initial": "I.",
                    "last": "Poulton"
                },
                {
                    "first": "N.",
                    "initial": "N.",
                    "last": "Lella"
                },
                {
                    "first": "R.",
                    "initial": "R.",
                    "last": "Roberts"
                },
                {
                    "first": "F.",
                    "initial": "F.",
                    "last": "Hartnell"
                },
                {
                    "first": "C.",
                    "initial": "C.",
                    "last": "Bliss"
                },
                {
                    "first": "K.",
                    "initial": "K.",
                    "last": "Sierra-Davidson"
                },
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "Powlson"
                },
                {
                    "first": "E.",
                    "initial": "E.",
                    "last": "Berrie"
                },
                {
                    "first": "R.",
                    "initial": "R.",
                    "last": "Tedder"
                },
                {
                    "first": "F.",
                    "initial": "F.",
                    "last": "Roman"
                },
                {
                    "first": "I.",
                    "initial": "I.",
                    "last": "De Ryck"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Nicosia"
                },
                {
                    "first": "N. J.",
                    "initial": "N.J.",
                    "last": "Sullivan"
                },
                {
                    "first": "D. A.",
                    "initial": "D.A.",
                    "last": "Stanley"
                },
                {
                    "first": "O. T.",
                    "initial": "O.T.",
                    "last": "Mbaya"
                },
                {
                    "first": "J. E.",
                    "initial": "J.E.",
                    "last": "Ledgerwood"
                },
                {
                    "first": "R. M.",
                    "initial": "R.M.",
                    "last": "Schwartz"
                },
                {
                    "first": "L.",
                    "initial": "L.",
                    "last": "Siani"
                },
                {
                    "first": "S.",
                    "initial": "S.",
                    "last": "Colloca"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Folgori"
                },
                {
                    "first": "S.",
                    "initial": "S.",
                    "last": "Di Marco"
                },
                {
                    "first": "R.",
                    "initial": "R.",
                    "last": "Cortese"
                },
                {
                    "first": "E.",
                    "initial": "E.",
                    "last": "Wright"
                },
                {
                    "first": "S.",
                    "initial": "S.",
                    "last": "Becker"
                },
                {
                    "first": "B. S.",
                    "initial": "B.S.",
                    "last": "Graham"
                },
                {
                    "first": "R. A.",
                    "initial": "R.A.",
                    "last": "Koup"
                },
                {
                    "first": "M. M.",
                    "initial": "M.M.",
                    "last": "Levine"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Volkmann"
                },
                {
                    "first": "P.",
                    "initial": "P.",
                    "last": "Chaplin"
                },
                {
                    "first": "A. J.",
                    "initial": "A.J.",
                    "last": "Pollard"
                },
                {
                    "first": "S. J.",
                    "initial": "S.J.",
                    "last": "Draper"
                },
                {
                    "first": "W. R.",
                    "initial": "W.R.",
                    "last": "Ballou"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Lawrie"
                },
                {
                    "first": "S. C.",
                    "initial": "S.C.",
                    "last": "Gilbert"
                },
                {
                    "first": "A. V.S.",
                    "initial": "A.V.S.",
                    "last": "Hill"
                }
            ],
            "doi": "10.1056/NEJMoa1411627",
            "firstpage": "1635",
            "issn": "00284793",
            "lastpage": "1646",
            "pmid": "25629663",
            "pub_year": 2016,
            "title": "A monovalent chimpanzee adenovirus ebola vaccine boosted with MVA",
            "volume": "374"
        },
        "b0175": {
            "authors": [
                {
                    "first": "Natalie E.R.",
                    "initial": "N.E.R.",
                    "last": "Beveridge"
                },
                {
                    "first": "David A.",
                    "initial": "D.A.",
                    "last": "Price"
                },
                {
                    "first": "Joseph P.",
                    "initial": "J.P.",
                    "last": "Casazza"
                },
                {
                    "first": "Ansar A.",
                    "initial": "A.A.",
                    "last": "Pathan"
                },
                {
                    "first": "Clare R.",
                    "initial": "C.R.",
                    "last": "Sander"
                },
                {
                    "first": "Tedi E.",
                    "initial": "T.E.",
                    "last": "Asher"
                },
                {
                    "first": "David R.",
                    "initial": "D.R.",
                    "last": "Ambrozak"
                },
                {
                    "first": "Melissa L.",
                    "initial": "M.L.",
                    "last": "Precopio"
                },
                {
                    "first": "Phillip",
                    "initial": "P.",
                    "last": "Scheinberg"
                },
                {
                    "first": "Nicola C.",
                    "initial": "N.C.",
                    "last": "Alder"
                },
                {
                    "first": "Mario",
                    "initial": "M.",
                    "last": "Roederer"
                },
                {
                    "first": "Richard A.",
                    "initial": "R.A.",
                    "last": "Koup"
                },
                {
                    "first": "Daniel C.",
                    "initial": "D.C.",
                    "last": "Douek"
                },
                {
                    "first": "Adrian V.S.",
                    "initial": "A.V.S.",
                    "last": "Hill"
                },
                {
                    "first": "Helen",
                    "initial": "H.",
                    "last": "McShane"
                }
            ],
            "doi": "10.1002/eji.200737504",
            "firstpage": "3089",
            "issn": "00142980",
            "lastpage": "3100",
            "pmid": "17948267",
            "pub_year": 2007,
            "title": "Immunisation with BCG and recombinant MVA85A induces long-lasting, polyfunctional Mycobacterium tuberculosis-specific CD4 + memory T lymphocyte populations",
            "volume": "37"
        },
        "b0180": {
            "authors": [
                {
                    "first": "Thomas",
                    "initial": "T.",
                    "last": "Lindenstr\u00f8m"
                },
                {
                    "first": "Else Marie",
                    "initial": "E.M.",
                    "last": "Agger"
                },
                {
                    "first": "Karen S.",
                    "initial": "K.S.",
                    "last": "Korsholm"
                },
                {
                    "first": "Patricia A.",
                    "initial": "P.A.",
                    "last": "Darrah"
                },
                {
                    "first": "Claus",
                    "initial": "C.",
                    "last": "Aagaard"
                },
                {
                    "first": "Robert A.",
                    "initial": "R.A.",
                    "last": "Seder"
                },
                {
                    "first": "Ida",
                    "initial": "I.",
                    "last": "Rosenkrands"
                },
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Andersen"
                }
            ],
            "doi": "10.4049/jimmunol.0801592",
            "firstpage": "8047",
            "issn": "00221767",
            "lastpage": "8055",
            "pmid": "19494330",
            "pub_year": 2009,
            "title": "Tuberculosis subunit vaccination provides long-term protective immunity characterized by multifunctional CD4 memory T cells",
            "volume": "182"
        },
        "b0185": {
            "authors": [
                {
                    "first": "Patricia A.",
                    "initial": "P.A.",
                    "last": "Darrah"
                },
                {
                    "first": "Dipti T.",
                    "initial": "D.T.",
                    "last": "Patel"
                },
                {
                    "first": "Paula M.",
                    "initial": "P.M.",
                    "last": "De Luca"
                },
                {
                    "first": "Ross W.B.",
                    "initial": "R.W.B.",
                    "last": "Lindsay"
                },
                {
                    "first": "Dylan F.",
                    "initial": "D.F.",
                    "last": "Davey"
                },
                {
                    "first": "Barbara J.",
                    "initial": "B.J.",
                    "last": "Flynn"
                },
                {
                    "first": "S\u00f8ren T.",
                    "initial": "S.T.",
                    "last": "Hoff"
                },
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Andersen"
                },
                {
                    "first": "Steven G.",
                    "initial": "S.G.",
                    "last": "Reed"
                },
                {
                    "first": "Sheldon L.",
                    "initial": "S.L.",
                    "last": "Morris"
                },
                {
                    "first": "Mario",
                    "initial": "M.",
                    "last": "Roederer"
                },
                {
                    "first": "Robert A.",
                    "initial": "R.A.",
                    "last": "Seder"
                }
            ],
            "doi": "10.1038/nm1592",
            "firstpage": "843",
            "issn": "10788956",
            "lastpage": "850",
            "pmid": "17558415",
            "pub_year": 2007,
            "title": "Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major",
            "volume": "13"
        },
        "b0190": {
            "authors": [
                {
                    "first": "Manvendra",
                    "initial": "M.",
                    "last": "Saxena"
                },
                {
                    "first": "Thi Thu Hao",
                    "initial": "T.T.H.",
                    "last": "Van"
                },
                {
                    "first": "Fiona J.",
                    "initial": "F.J.",
                    "last": "Baird"
                },
                {
                    "first": "Peter J.",
                    "initial": "P.J.",
                    "last": "Coloe"
                },
                {
                    "first": "Peter M.",
                    "initial": "P.M.",
                    "last": "Smooker"
                }
            ],
            "doi": "10.1099/mic.0.049601-0",
            "firstpage": "1",
            "issn": "13500872",
            "lastpage": "11",
            "pmid": "23175507",
            "pub_year": 2013,
            "title": "Pre-existing immunity against vaccine vectors - friend or foe?",
            "volume": "159"
        },
        "b0195": {
            "authors": [
                {
                    "first": "Ashley J.",
                    "initial": "A.J.",
                    "last": "Jacobs"
                },
                {
                    "first": "Juthathip",
                    "initial": "J.",
                    "last": "Mongkolsapaya"
                },
                {
                    "first": "Gavin R.",
                    "initial": "G.R.",
                    "last": "Screaton"
                },
                {
                    "first": "Helen",
                    "initial": "H.",
                    "last": "McShane"
                },
                {
                    "first": "Robert J.",
                    "initial": "R.J.",
                    "last": "Wilkinson"
                }
            ],
            "doi": "10.1016/j.tube.2016.08.001",
            "firstpage": "102",
            "issn": "14729792",
            "lastpage": "113",
            "pmid": "27865379",
            "pub_year": 2016,
            "title": "Antibodies and tuberculosis",
            "volume": "101"
        }
    },
    "body_text": [
        {
            "endOffset": 18479,
            "parents": [],
            "secId": "s0005",
            "sentence": "Tuberculosis (TB) is now the leading single infectious disease killer in the world despite an annual 2% reduction in TB worldwide.",
            "startOffset": 18349,
            "title": "Background"
        },
        {
            "endOffset": 31254,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "There were no safety concerns in the Starter Group.",
            "startOffset": 31203,
            "title": "Vaccine safety"
        },
        {
            "endOffset": 35599,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Results"
                },
                {
                    "id": "s0065",
                    "title": "Vaccine immunogenicity"
                }
            ],
            "secId": "s0070",
            "sentence": "MVA85A boosted responses were not significantly different in Group B (D63) and Group C (D126).",
            "startOffset": 35505,
            "title": "Vaccination with ChAdOx1 85A boosted ex-vivo Ag85A-specific IFN-\u03b3 responses that are further boosted by MVA85A"
        },
        {
            "endOffset": 40570,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Results"
                },
                {
                    "id": "s0065",
                    "title": "Vaccine immunogenicity"
                }
            ],
            "secId": "s0085",
            "sentence": "Vaccine-induced anti-ChAdOx1 IgG fold change was significant in Groups B and C.",
            "startOffset": 40491,
            "title": "Immunoglobulin G (IgG) responses following ChAdOx1 85A and MVA85A vaccination"
        },
        {
            "endOffset": 30056,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0045",
            "sentence": "Mean optical density (OD) of triplicate blank wells were subtracted from mean OD of test sample triplicate.",
            "startOffset": 29949,
            "title": "Enzyme-linked immunosorbent assay (ELISA)"
        },
        {
            "endOffset": 43987,
            "parents": [],
            "refoffsets": {
                "b0065": {
                    "endOffset": 43986,
                    "startOffset": 43970
                },
                "b0080": {
                    "endOffset": 43986,
                    "startOffset": 43970
                },
                "b0085": {
                    "endOffset": 43986,
                    "startOffset": 43970
                },
                "b0160": {
                    "endOffset": 43986,
                    "startOffset": 43970
                },
                "b0165": {
                    "endOffset": 43986,
                    "startOffset": 43970
                },
                "b0170": {
                    "endOffset": 43986,
                    "startOffset": 43970
                }
            },
            "secId": "s0090",
            "sentence": "The responses in subjects boosted with MVA85A were higher than those in the ChAdOx1 85A alone group, reflecting the superior immunogenicity of a prime-boost combination reported for other pathogens [13,16,17,32\u201334].",
            "startOffset": 43772,
            "title": "Discussion:"
        },
        {
            "endOffset": 35748,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Results"
                },
                {
                    "id": "s0065",
                    "title": "Vaccine immunogenicity"
                }
            ],
            "secId": "s0070",
            "sentence": "ChAdOx1-specific responses were detected in Groups A, B and C (Fig. 2II) peaking at D14 (Group A p = 0.0015; Group B p = 0.0005; Group C p = 0.0278).",
            "startOffset": 35599,
            "title": "Vaccination with ChAdOx1 85A boosted ex-vivo Ag85A-specific IFN-\u03b3 responses that are further boosted by MVA85A"
        },
        {
            "endOffset": 38404,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Results"
                },
                {
                    "id": "s0065",
                    "title": "Vaccine immunogenicity"
                }
            ],
            "secId": "s0080",
            "sentence": "Ag85A-specific polyfunctional CD4+ T cell cytokine responses were enhanced further by MVA85A at D63 compared to D56 in Group B (p = 0.001 for g+t+2+, g+t+ and g+2+) and at D126 compared to D119 in Group C (p = 0.021 for g+t+2+ and p = 0.001 for g+2+).",
            "startOffset": 38153,
            "title": "Polyfunctional CD4+ and CD8+ T cells are detectable after ChAdOx1 85A and MVA85A vaccinations"
        },
        {
            "endOffset": 41863,
            "parents": [],
            "secId": "s0090",
            "sentence": "Vaccination with ChAdOx1 85A induced Ag85A-specific IFN-\u03b3 responses.",
            "startOffset": 41795,
            "title": "Discussion:"
        },
        {
            "endOffset": 27731,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0040",
            "sentence": "Duplicate tubes were then added to 9 ml FACS lysing solution (BD Bioscience) and incubated at room temperature in the dark for 10 mins before centrifuging at 1500 rpm for 7 mins.",
            "startOffset": 27553,
            "title": "Whole blood intracellular cytokine staining (WB ICS)"
        },
        {
            "endOffset": 32149,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "One Group B volunteer reported severe feverishness, myalgia and malaise following MVA85A, and a second volunteer, also in Group B reported severe headache.",
            "startOffset": 31994,
            "title": "Vaccine safety"
        },
        {
            "endOffset": 21946,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0020",
            "sentence": "Visits occurred at the Centre for Clinical Vaccinology and Tropical Medicine (CCVTM), Oxford, and the NIHR Wellcome Trust Clinical Research Facility, Birmingham (NIHR WTCRF).",
            "startOffset": 21772,
            "title": "Participants"
        },
        {
            "endOffset": 27552,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0040",
            "sentence": "The following morning, 50ul 20 mM EDTA was added to each tube and incubated at room temperature for 15 mins.",
            "startOffset": 27444,
            "title": "Whole blood intracellular cytokine staining (WB ICS)"
        },
        {
            "endOffset": 45688,
            "parents": [],
            "secId": "s0090",
            "sentence": "IgG antibodies to the vectors were detected following vaccination; however no association between anti-vector and anti-Ag85A IgG responses is evident.",
            "startOffset": 45538,
            "title": "Discussion:"
        },
        {
            "endOffset": 29820,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0045",
            "sentence": "Goat anti-human \u03b3-chain whole IgG alkaline phosphatase conjugate (Sigma Aldrich) was used for capture of bound serum IgG.",
            "startOffset": 29699,
            "title": "Enzyme-linked immunosorbent assay (ELISA)"
        },
        {
            "endOffset": 19876,
            "parents": [],
            "refoffsets": {
                "b0060": {
                    "endOffset": 19875,
                    "startOffset": 19868
                },
                "b0065": {
                    "endOffset": 19875,
                    "startOffset": 19868
                }
            },
            "secId": "s0005",
            "sentence": "Heterologous \u2018prime-boost\u2019 vaccination strategies, using different viral vectored vaccines expressing proteins from malaria, have shown strong and sustained cellular immune responses correlating with malaria protection [12,13].",
            "startOffset": 19649,
            "title": "Background"
        },
        {
            "endOffset": 29948,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0045",
            "sentence": "Absorbance was measured at 405 nm.",
            "startOffset": 29914,
            "title": "Enzyme-linked immunosorbent assay (ELISA)"
        },
        {
            "endOffset": 20334,
            "parents": [],
            "refoffsets": {
                "b0075": {
                    "endOffset": 20333,
                    "startOffset": 20329
                }
            },
            "secId": "s0005",
            "sentence": "Recently, a protein adjuvanted subunit vaccine M72, conferred 54% protection against TB disease in M.tb latently infected subjects [15].",
            "startOffset": 20198,
            "title": "Background"
        },
        {
            "endOffset": 30465,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0050",
            "sentence": "One way ANOVA was used to detect differences in baseline demographics across groups.",
            "startOffset": 30381,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 40742,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Results"
                },
                {
                    "id": "s0065",
                    "title": "Vaccine immunogenicity"
                }
            ],
            "secId": "s0085",
            "sentence": "The induced ChAdOx1 response was significantly higher at D63 and remained high up to D140 in Group B (D63 p = 0.021; D84 p = 0.027 and D140 p = 0.007 all compared to D14).",
            "startOffset": 40571,
            "title": "Immunoglobulin G (IgG) responses following ChAdOx1 85A and MVA85A vaccination"
        },
        {
            "endOffset": 44401,
            "parents": [],
            "secId": "s0090",
            "sentence": "Here we demonstrate that polyfunctional CD4+ T cells are induced by ChAdOx1 85A vaccination and homologous boosting was required to obtain polyfunctional CD8+ T cell responses, but had minimal effect on the detected polyfunctional CD4+ T cells responses.",
            "startOffset": 44147,
            "title": "Discussion:"
        },
        {
            "endOffset": 44799,
            "parents": [],
            "secId": "s0090",
            "sentence": "Low baseline (D0) vector-specific IFN-\u03b3 responses were detected in volunteers from the 4 study groups (median ELISpot responses of 3 SFC/1 \u00d7 106 PBMC for MVA CD4, 4 SFC/1 \u00d7 106 PBMC for MVA CD8 of and 102 SFC/1 \u00d7 106 PBMC for ChAdOx1).",
            "startOffset": 44564,
            "title": "Discussion:"
        },
        {
            "endOffset": 21478,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "All trial documents were approved by the Medicines and Healthcare Regulatory Agency (MHRA, EudraCT 2012-005118-21) and South Central \u2013 Oxford A Research Ethics Committee (reference: 13/SC/0098).",
            "startOffset": 21284,
            "title": "Trial design"
        },
        {
            "endOffset": 44563,
            "parents": [],
            "refoffsets": {
                "b0190": {
                    "endOffset": 44487,
                    "startOffset": 44483
                }
            },
            "secId": "s0090",
            "sentence": "Immune responses to viral vectors may potentially modify Ag85A-specific responses [38], to this end we have tested vector-specific cellular and humoral responses.",
            "startOffset": 44401,
            "title": "Discussion:"
        },
        {
            "endOffset": 19061,
            "parents": [],
            "secId": "s0005",
            "sentence": "However, the lack of consistent protection against adult pulmonary TB means a more universally effective vaccine is urgently needed.",
            "startOffset": 18929,
            "title": "Background"
        },
        {
            "endOffset": 21988,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0020",
            "sentence": "All vaccination visits were at the CCVTM.",
            "startOffset": 21947,
            "title": "Participants"
        },
        {
            "endOffset": 31695,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "Local redness and swelling across all vaccinations were comparable with no significant difference seen (p > 0.05) (Supplementary Fig. 2).",
            "startOffset": 31558,
            "title": "Vaccine safety"
        },
        {
            "endOffset": 32822,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "One volunteer in Group C had a moderate lymphopaenia considered possibly related to MVA85A which was ongoing at the end of the study.",
            "startOffset": 32689,
            "title": "Vaccine safety"
        },
        {
            "endOffset": 26538,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0035",
            "sentence": "Staphylococcal enterotoxin B (SEB) (Sigma) (10 \u03bcg/ml) was used as a positive control and unstimulated PBMC as a negative control.",
            "startOffset": 26409,
            "title": "Enzyme-Linked ImmunoSpot (ELISpot)"
        },
        {
            "endOffset": 39361,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Results"
                },
                {
                    "id": "s0065",
                    "title": "Vaccine immunogenicity"
                }
            ],
            "secId": "s0085",
            "sentence": "A similar pattern was observed with 2.5 \u00d7 1010 vp ChAdOx1 85A, with responses being significantly higher at D14 than D0 (p = 0.0005 for all time points up to D84 and p = 0.001 at D168 (Group A), P = 0.0005 up to D140 and p = 0.002 for D224 (Group B) and p = 0.0005 for all time points in Group C up to D147 and p = 0.001 for D287.",
            "startOffset": 39031,
            "title": "Immunoglobulin G (IgG) responses following ChAdOx1 85A and MVA85A vaccination"
        },
        {
            "endOffset": 37239,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Results"
                },
                {
                    "id": "s0065",
                    "title": "Vaccine immunogenicity"
                }
            ],
            "secId": "s0075",
            "sentence": "Boosting with MVA85A further enhanced this response in Groups B and C (D63 p = 0.001; D126 p = 0.003 respectively) and were comparable between the two groups (p = 0.379), remaining significantly high at the end of follow-up (Group B: D0 v D224 p = 0.004; Group C: D0 v D203 p = 0.005).",
            "startOffset": 36954,
            "title": "Vaccination with ChAdOx1 85A induces intracellular cytokine responses in Ag85A-specific CD4+ and CD8+ T cells"
        },
        {
            "endOffset": 42027,
            "parents": [],
            "secId": "s0090",
            "sentence": "As expected from previous studies, these responses were boosted with MVA85A vaccination, and the direct effect of homologous boosting with ChAdOx1 85A was minimal.",
            "startOffset": 41864,
            "title": "Discussion:"
        },
        {
            "endOffset": 38775,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Results"
                },
                {
                    "id": "s0065",
                    "title": "Vaccine immunogenicity"
                }
            ],
            "secId": "s0080",
            "sentence": "Results of the detected cytokines combinations are presented.",
            "startOffset": 38714,
            "title": "Polyfunctional CD4+ and CD8+ T cells are detectable after ChAdOx1 85A and MVA85A vaccinations"
        },
        {
            "endOffset": 34287,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Results"
                },
                {
                    "id": "s0065",
                    "title": "Vaccine immunogenicity"
                }
            ],
            "secId": "s0070",
            "sentence": "No difference was detected in the magnitude of the MVA85A-boosted responses between Group B and Group C one week post-MVA85A (p = 0.2274).",
            "startOffset": 34149,
            "title": "Vaccination with ChAdOx1 85A boosted ex-vivo Ag85A-specific IFN-\u03b3 responses that are further boosted by MVA85A"
        },
        {
            "endOffset": 35296,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Results"
                },
                {
                    "id": "s0065",
                    "title": "Vaccine immunogenicity"
                }
            ],
            "secId": "s0070",
            "sentence": "Baseline PPD-specific IFN-\u03b3 responses were not boosted by ChAdOx1 85A in the Starter Group or groups A and C, however group B had a significant increase in responses between D0 and D14 (p = 0.007) (Supplementary Table 2).",
            "startOffset": 35075,
            "title": "Vaccination with ChAdOx1 85A boosted ex-vivo Ag85A-specific IFN-\u03b3 responses that are further boosted by MVA85A"
        },
        {
            "endOffset": 28006,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0040",
            "sentence": "Supernatant was discarded and the cell pellet resuspended in 1 ml PBS with 10% DMSO and transferred to a cryovial for freezing and batched analysis at the end of the trial.",
            "startOffset": 27834,
            "title": "Whole blood intracellular cytokine staining (WB ICS)"
        },
        {
            "endOffset": 45537,
            "parents": [],
            "secId": "s0090",
            "sentence": "Here, we show that vaccination with ChAdOx1 85A enhances Ag85A-specific IgG responses, which in turn are boosted by MVA85A.",
            "startOffset": 45414,
            "title": "Discussion:"
        },
        {
            "endOffset": 25020,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0030",
            "sentence": "Starter Group and Group A were followed-up at: D2, D14, D28, D56, D84 and D168, Group B: D2, D14, D28, D56, D58, D63, D84, D140 and D224, and Group C: D2, D14, D28, D30, D42, D56, D119, D121, D126, D147, D203 and D287.",
            "startOffset": 24802,
            "title": "Clinical interventions"
        },
        {
            "endOffset": 25088,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0030",
            "sentence": "Solicited and unsolicited AEs were graded mild, moderate or severe.",
            "startOffset": 25021,
            "title": "Clinical interventions"
        },
        {
            "endOffset": 31053,
            "parents": [],
            "secId": "s0055",
            "sentence": "One volunteer in Group C withdrew prior to their final visit; all data prior to the point of withdrawal were included in analysis.",
            "startOffset": 30923,
            "title": "Results"
        },
        {
            "endOffset": 24520,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "b0070": {
                    "endOffset": 24363,
                    "startOffset": 24359
                }
            },
            "secId": "s0030",
            "sentence": "Following our previous trial results, where two doses of AERAS-402 followed by MVA85A was the most potent regime for the induction of antigen-specific CD8+ T cell responses [14], we added Group C, whereby 12 volunteers were enrolled to receive two doses of ChAdOx1 85A 2.5 \u00d7 1010 vp (D0 and D28) with MVA85A 1 \u00d7 108 pfu boost at D119.",
            "startOffset": 24186,
            "title": "Clinical interventions"
        },
        {
            "endOffset": 18586,
            "parents": [],
            "refoffsets": {
                "b0005": {
                    "endOffset": 18585,
                    "startOffset": 18582
                }
            },
            "secId": "s0005",
            "sentence": "In 2017, an estimated 1.6 million people died from TB, with 10 million new cases throughout the world [1].",
            "startOffset": 18480,
            "title": "Background"
        },
        {
            "endOffset": 45023,
            "parents": [],
            "refoffsets": {
                "b0070": {
                    "endOffset": 45022,
                    "startOffset": 45018
                }
            },
            "secId": "s0090",
            "sentence": "MVA-specific IFN-\u03b3 responses were detected following MVA85A vaccination as we have shown previously [14].",
            "startOffset": 44918,
            "title": "Discussion:"
        },
        {
            "endOffset": 27361,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0040",
            "sentence": "The co-stimulatory antibodies \u03b1-CD28 and \u03b1-CD49d were added to each tube at a final concentration of 0.5 \u00b5g/ml and tubes were then incubated at 37 \u00b0C, 5% CO2 for 5 h before Brefeldin A was added at a final concentration of 5ug/ml.",
            "startOffset": 27131,
            "title": "Whole blood intracellular cytokine staining (WB ICS)"
        },
        {
            "endOffset": 32360,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "A volunteer in Group A reported transient axillary lymphadenopathy.",
            "startOffset": 32293,
            "title": "Vaccine safety"
        },
        {
            "endOffset": 38713,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Results"
                },
                {
                    "id": "s0065",
                    "title": "Vaccine immunogenicity"
                }
            ],
            "secId": "s0080",
            "sentence": "Ag85A-specific g+t+CD8+ T cells were significantly higher than D0 at D224 in Group B (p = 0.0098) and at D28, D42, D126 and D203 (p = 0.002) and at D119 (p = 0.005) in Group C (Fig. 4IV).",
            "startOffset": 38526,
            "title": "Polyfunctional CD4+ and CD8+ T cells are detectable after ChAdOx1 85A and MVA85A vaccinations"
        },
        {
            "endOffset": 34884,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Results"
                },
                {
                    "id": "s0065",
                    "title": "Vaccine immunogenicity"
                }
            ],
            "secId": "s0070",
            "sentence": "Groups B and C had a median AUC of 14985 and 14978 SFC/1 \u00d7 106 PBMC respectively, compared with 9527 SFC/1 \u00d7 106 PBMC in the MVA85A alone group, although the difference between the groups was not significant.",
            "startOffset": 34676,
            "title": "Vaccination with ChAdOx1 85A boosted ex-vivo Ag85A-specific IFN-\u03b3 responses that are further boosted by MVA85A"
        },
        {
            "endOffset": 39030,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Results"
                },
                {
                    "id": "s0065",
                    "title": "Vaccine immunogenicity"
                }
            ],
            "secId": "s0085",
            "sentence": "Ag85A-specific IgG responses were induced by 5 \u00d7 109 vp ChAdOx1 85A, peaking at D28 and remaining higher than baseline at D168 (Starter Group p = 0.031 for all time points).",
            "startOffset": 38857,
            "title": "Immunoglobulin G (IgG) responses following ChAdOx1 85A and MVA85A vaccination"
        },
        {
            "endOffset": 28565,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0040",
            "sentence": "CD4+ and CD8+ T cell cytokine responses were measured in singlet CD14-CD19-CD3+ cells (Supplementary Figure 1).",
            "startOffset": 28454,
            "title": "Whole blood intracellular cytokine staining (WB ICS)"
        },
        {
            "endOffset": 45139,
            "parents": [],
            "secId": "s0090",
            "sentence": "The detected cellular anti-vector responses were not associated with the vaccine-induced insert-specific responses.",
            "startOffset": 45024,
            "title": "Discussion:"
        },
        {
            "endOffset": 34148,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Results"
                },
                {
                    "id": "s0065",
                    "title": "Vaccine immunogenicity"
                }
            ],
            "secId": "s0070",
            "sentence": "A second dose of ChAdOx1 85A (Group C) did not further boost these responses (Fig. 2I), however they were significantly boosted with MVA85A vaccination at D56 and D119 in Group B and Group C volunteers respectively (p = 0.0005 for Group B D63 and p = 0.001 for Group C D126, (Fig. 2I)) remaining significantly above baseline at the end of the study (Group B D224 p = 0.0005; for; Group C D287 p = 0.001).",
            "startOffset": 33744,
            "title": "Vaccination with ChAdOx1 85A boosted ex-vivo Ag85A-specific IFN-\u03b3 responses that are further boosted by MVA85A"
        },
        {
            "endOffset": 30922,
            "parents": [],
            "secId": "s0055",
            "sentence": "Between 22nd July 2013 and 30th June 2015, 42 volunteers were enrolled (Fig. 1 Consort diagram).",
            "startOffset": 30826,
            "title": "Results"
        },
        {
            "endOffset": 22339,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0020",
            "sentence": "Baseline biochemical and haematological analysis, serological testing for HIV, hepatitis B and hepatitis C were performed to ensure no abnormalities warranting exclusion.",
            "startOffset": 22169,
            "title": "Participants"
        },
        {
            "endOffset": 40490,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Results"
                },
                {
                    "id": "s0065",
                    "title": "Vaccine immunogenicity"
                }
            ],
            "secId": "s0085",
            "sentence": "ChAdOx1 85A at a dose of 2.5 \u00d7 1010 vp induced significant ChAdOx1-specific IgG in Groups A, B and C (Group A p = 0.0005 at D14 up to D84 and p = 0.001 at D168; Group B p = 0.001 at D14, p = 0.0005 at D28 up to D140 and p = 0.002 at D224; Group C p = 0.02 at D14, p = 0.012 at D28, p = 0.0005 at D42 up to D147) (Supplementary Fig. 3II).",
            "startOffset": 40153,
            "title": "Immunoglobulin G (IgG) responses following ChAdOx1 85A and MVA85A vaccination"
        },
        {
            "endOffset": 29224,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0045",
            "sentence": "Immunoglobulin G (IgG) levels were measured in serum collected on D0, D14, D28, D56, D84 and D168 (Starter Group and Group A), at D0, D14, D28, D56, D63, D84, D140 and D224 (Group B) and at D0, D14, D28, D42, D56, D119, D126, D147 and D287 (Group C).",
            "startOffset": 28974,
            "title": "Enzyme-linked immunosorbent assay (ELISA)"
        },
        {
            "endOffset": 23080,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Both vaccines were stored prior to use at the CCVTM in a secure locked, monitored \u221280 \u00b0C freezer.",
            "startOffset": 22983,
            "title": "Vaccines"
        },
        {
            "endOffset": 22982,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "b0090": {
                    "endOffset": 22909,
                    "startOffset": 22905
                }
            },
            "secId": "s0025",
            "sentence": "MVA85A (lot no. 0050811) was constructed as previously documented [18], and produced under GMP conditions by IDT Biologika GmbH (IDT), Germany.",
            "startOffset": 22839,
            "title": "Vaccines"
        },
        {
            "endOffset": 43382,
            "parents": [],
            "refoffsets": {
                "b0125": {
                    "endOffset": 43191,
                    "startOffset": 43187
                },
                "b0130": {
                    "endOffset": 43297,
                    "startOffset": 43293
                },
                "b0135": {
                    "endOffset": 43381,
                    "startOffset": 43374
                },
                "b0140": {
                    "endOffset": 43381,
                    "startOffset": 43374
                }
            },
            "secId": "s0090",
            "sentence": "Other cytokines are shown to play a role in protection against TB; blocking TNF-\u03b1 is reported to be associated with susceptibility to TB [25], IL-2, another Th1 cytokine, induces proliferation and maintenance of effector CD4+ and CD8+ T cells [26] and IL-17 has been associated with protection against TB in mice and humans [27,28].",
            "startOffset": 43050,
            "title": "Discussion:"
        },
        {
            "endOffset": 28797,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0040",
            "sentence": "Antigen-specific cytokine responses are presented by subtracting background unstimulated responses.",
            "startOffset": 28698,
            "title": "Whole blood intracellular cytokine staining (WB ICS)"
        },
        {
            "endOffset": 45998,
            "parents": [],
            "secId": "s0090",
            "sentence": "Whilst it is likely that more than one antigen is needed in a subunit vaccine for protection in genetically diverse human populations, this experimental medicine study demonstrates proof-of-concept of a prime-boost approach with a novel simian adenoviral vector prime and an MVA boost in BCG-vaccinated adults.",
            "startOffset": 45688,
            "title": "Discussion:"
        },
        {
            "endOffset": 29698,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0045",
            "sentence": "Serum pooled from five high IgG responders was the positive control with serum from BCG-na\u00efve individuals as negative control.",
            "startOffset": 29572,
            "title": "Enzyme-linked immunosorbent assay (ELISA)"
        },
        {
            "endOffset": 35001,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Results"
                },
                {
                    "id": "s0065",
                    "title": "Vaccine immunogenicity"
                }
            ],
            "secId": "s0070",
            "sentence": "An increase in Ag85A-specific responses was detected in the Starter Group but did not reach statistical significance.",
            "startOffset": 34884,
            "title": "Vaccination with ChAdOx1 85A boosted ex-vivo Ag85A-specific IFN-\u03b3 responses that are further boosted by MVA85A"
        },
        {
            "endOffset": 18782,
            "parents": [],
            "refoffsets": {
                "b0005": {
                    "endOffset": 18781,
                    "startOffset": 18778
                }
            },
            "secId": "s0005",
            "sentence": "The End TB strategy of global eradication of TB seeks to address this pressing issue, and one of the most valuable tools for its success is the development of a safe and effective TB vaccine [1].",
            "startOffset": 18587,
            "title": "Background"
        },
        {
            "endOffset": 21283,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "We conducted a phase I, open label, dose escalation clinical trial in 42 BCG-vaccinated UK adults.",
            "startOffset": 21185,
            "title": "Trial design"
        },
        {
            "endOffset": 20413,
            "parents": [],
            "secId": "s0005",
            "sentence": "ChAdOx1 85A is a novel chimpanzee adenoviral vectored vaccine expressing Ag85A.",
            "startOffset": 20334,
            "title": "Background"
        },
        {
            "endOffset": 20052,
            "parents": [],
            "secId": "s0005",
            "sentence": "A recombinant adenoviral vaccine candidate, AERAS-402, has been evaluated as a prime-boost regimen with MVA85A in a phase I clinical trial in healthy BCG-vaccinated UK adults.",
            "startOffset": 19877,
            "title": "Background"
        },
        {
            "endOffset": 20613,
            "parents": [],
            "refoffsets": {
                "b0080": {
                    "endOffset": 20612,
                    "startOffset": 20608
                }
            },
            "secId": "s0005",
            "sentence": "An advantage of simian adenoviral vectors over human adenoviral vectors is the low prevalence of pre-existing anti-vector antibodies in humans, a factor limiting the use of adenoviruses to date [16].",
            "startOffset": 20414,
            "title": "Background"
        },
        {
            "endOffset": 47226,
            "parents": [],
            "secId": "s0100",
            "sentence": "The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health.",
            "startOffset": 47106,
            "title": "Financial support statement"
        },
        {
            "endOffset": 29310,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0045",
            "sentence": "Recombinant Ag85A (Lionex, Germany) was used to measure Ag85A-specific IgG responses.",
            "startOffset": 29225,
            "title": "Enzyme-linked immunosorbent assay (ELISA)"
        },
        {
            "endOffset": 31773,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "The majority of systemic, solicited AEs were also mild to moderate in nature.",
            "startOffset": 31696,
            "title": "Vaccine safety"
        },
        {
            "endOffset": 36953,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Results"
                },
                {
                    "id": "s0065",
                    "title": "Vaccine immunogenicity"
                }
            ],
            "secId": "s0075",
            "sentence": "ChAdOx1 85A induced Ag85A specific IFN-\u03b3+, TNF-\u03b1+, IL-2+ and IL-17+ CD4+ T cells in Groups A, B and C at D14 (Fig. 3I; p = 0.002) which remained significantly higher at D56 in Group B (p = 0.002).",
            "startOffset": 36757,
            "title": "Vaccination with ChAdOx1 85A induces intracellular cytokine responses in Ag85A-specific CD4+ and CD8+ T cells"
        },
        {
            "endOffset": 21162,
            "parents": [],
            "secId": "s0005",
            "sentence": "The aim of this first-in-human experimental medicine trial was to evaluate the safety and immunogenicity of ChAdOx1 85A, alone and as a prime-boost regime with MVA85A in healthy, BCG-vaccinated UK adults.",
            "startOffset": 20958,
            "title": "Background"
        },
        {
            "endOffset": 20798,
            "parents": [],
            "refoffsets": {
                "b0085": {
                    "endOffset": 20797,
                    "startOffset": 20793
                }
            },
            "secId": "s0005",
            "sentence": "The vector, ChAdOx1, expressing two influenza antigens, NP and M1, has previously been evaluated in a small phase I dose escalation trial and was found to be safe and immunogenic [17].",
            "startOffset": 20614,
            "title": "Background"
        },
        {
            "endOffset": 23162,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Both vaccines were administered intramuscularly in the deltoid region of the arm.",
            "startOffset": 23081,
            "title": "Vaccines"
        },
        {
            "endOffset": 23454,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0030",
            "sentence": "Six volunteers were enrolled into the Starter Group and received ChAdOx1 85A at a dose of 5 \u00d7 109 virus particles (vp) on day 0 (D0), a safety review was performed 48 h following vaccination of the first volunteer before vaccination of the subsequent five volunteers.",
            "startOffset": 23187,
            "title": "Clinical interventions"
        },
        {
            "endOffset": 30741,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0050",
            "sentence": "The Mann Whitney U test was used to detect differences between groups, the Kruskal-Wallis test was used for looking at differences between more than two groups and the Wilcoxon matched-pairs signed rank test was used for differences between time points within the same group.",
            "startOffset": 30466,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 24185,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0030",
            "sentence": "No safety concerns were raised, and a further 23 volunteers were randomised to Group A (ChAdOx1 85A 2.5 \u00d7 1010 vp at D0) or Group B (ChAdOx1 85A 2.5 \u00d7 1010 vp at D0 with MVA85A 1 \u00d7 108 plaque forming units (pfu) boost at D56) using sequentially numbered, sealed envelopes prepared by an independent statistician and opened by the trial clinician at the time of volunteer enrolment.",
            "startOffset": 23804,
            "title": "Clinical interventions"
        },
        {
            "endOffset": 33569,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Results"
                },
                {
                    "id": "s0065",
                    "title": "Vaccine immunogenicity"
                }
            ],
            "secId": "s0070",
            "sentence": "A single dose (2.5 \u00d7 1010 vp) of ChAdOx1 85A induced a significant increase in Ag85A-specific ex-vivo ELISpot responses in Groups A, B and C compared to baseline.",
            "startOffset": 33407,
            "title": "Vaccination with ChAdOx1 85A boosted ex-vivo Ag85A-specific IFN-\u03b3 responses that are further boosted by MVA85A"
        },
        {
            "endOffset": 19186,
            "parents": [],
            "refoffsets": {
                "b0010": {
                    "endOffset": 19185,
                    "startOffset": 19180
                },
                "b0015": {
                    "endOffset": 19185,
                    "startOffset": 19180
                },
                "b0020": {
                    "endOffset": 19185,
                    "startOffset": 19180
                },
                "b0025": {
                    "endOffset": 19185,
                    "startOffset": 19180
                }
            },
            "secId": "s0005",
            "sentence": "Subunit vaccines to boost the efficacy of BCG allow the retention of the protective benefits against systemic disease [2\u20135].",
            "startOffset": 19062,
            "title": "Background"
        },
        {
            "endOffset": 31186,
            "parents": [],
            "secId": "s0055",
            "sentence": "Baseline demographics including age, sex and time between BCG and enrolment, were comparable between groups (Supplementary Table 1).",
            "startOffset": 31054,
            "title": "Results"
        },
        {
            "endOffset": 36643,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Results"
                },
                {
                    "id": "s0065",
                    "title": "Vaccine immunogenicity"
                }
            ],
            "secId": "s0070",
            "sentence": "There was no statistical association between ELISpot insert and vector responses: For ChAdOx1 vs Ag85A at D14 for Groups A, B and C combined and at D42, following a second ChadOx1 85A dose, in Group C and for MVA vs Ag85A at D 63 (Group B) and D126 (Group C), all p > 0.05 (Spearman test).",
            "startOffset": 36354,
            "title": "Vaccination with ChAdOx1 85A boosted ex-vivo Ag85A-specific IFN-\u03b3 responses that are further boosted by MVA85A"
        },
        {
            "endOffset": 29571,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0045",
            "sentence": "The assay was performed in triplicate with serum diluted 1:10 in Casein blocking buffer (Sigma).",
            "startOffset": 29475,
            "title": "Enzyme-linked immunosorbent assay (ELISA)"
        },
        {
            "endOffset": 40942,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Results"
                },
                {
                    "id": "s0065",
                    "title": "Vaccine immunogenicity"
                }
            ],
            "secId": "s0085",
            "sentence": "Significantly higher fold change IgG response was observed at all time points up to D147 compared to D14 in Group C (D28 p = 0.016, D56 p = 0.001 and p = 0.0005 for all other time points up to D147).",
            "startOffset": 40743,
            "title": "Immunoglobulin G (IgG) responses following ChAdOx1 85A and MVA85A vaccination"
        },
        {
            "endOffset": 42877,
            "parents": [],
            "refoffsets": {
                "b0105": {
                    "endOffset": 42876,
                    "startOffset": 42869
                },
                "b0110": {
                    "endOffset": 42876,
                    "startOffset": 42869
                },
                "b0115": {
                    "endOffset": 42876,
                    "startOffset": 42869
                },
                "b0120": {
                    "endOffset": 42876,
                    "startOffset": 42869
                }
            },
            "secId": "s0090",
            "sentence": "The critical role of IFN-\u03b3 in control of TB has been reported in humans and animal models and we have shown that vaccine-induced Mycobacteria-specific IFN-\u03b3 secreting cells are associated with reduced risk of TB disease [21\u201324].",
            "startOffset": 42649,
            "title": "Discussion:"
        },
        {
            "endOffset": 31453,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "Volunteers enrolled in Groups A, B and C reported expected local AEs, the majority of which were mild/moderate in nature (Table 1).",
            "startOffset": 31322,
            "title": "Vaccine safety"
        },
        {
            "endOffset": 32292,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "Frequency of unsolicited AEs, including abnormalities of blood safety profile, considered to be related to vaccination are included in Table 1.",
            "startOffset": 32149,
            "title": "Vaccine safety"
        },
        {
            "endOffset": 46125,
            "parents": [],
            "secId": "s0090",
            "sentence": "Further work is needed to identify novel antigenic targets for inclusion in a multi-antigenic prime-boost vaccination regimen.",
            "startOffset": 45999,
            "title": "Discussion:"
        },
        {
            "endOffset": 26772,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0040",
            "sentence": "WB cytokine responses were measured in samples collected at D0, D14 and D168 (Group A); D0, D14, D56, D63 and D224 (Group B); and D0, D14, D28, D42, D119, D126 and D203 (Group C).",
            "startOffset": 26593,
            "title": "Whole blood intracellular cytokine staining (WB ICS)"
        },
        {
            "endOffset": 28453,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0040",
            "sentence": "Data was analysed using FlowJo (Tree Star).",
            "startOffset": 28410,
            "title": "Whole blood intracellular cytokine staining (WB ICS)"
        },
        {
            "endOffset": 37410,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Results"
                },
                {
                    "id": "s0065",
                    "title": "Vaccine immunogenicity"
                }
            ],
            "secId": "s0075",
            "sentence": "Ag85A-specific IFN-\u03b3+, TNF-\u03b1+ CD8+ T cells were induced by ChAdOx1 85A vaccination (Fig. 3II) and were boosted by MVA85A (Group B: D63 p = 0.008; Group C: D126 p = 0.019).",
            "startOffset": 37239,
            "title": "Vaccination with ChAdOx1 85A induces intracellular cytokine responses in Ag85A-specific CD4+ and CD8+ T cells"
        },
        {
            "endOffset": 35875,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Results"
                },
                {
                    "id": "s0065",
                    "title": "Vaccine immunogenicity"
                }
            ],
            "secId": "s0070",
            "sentence": "Group A remained significantly higher until D28 (p = 0.027), Group B until D56 (p = 0.005) and Group C until D119 (p = 0.024).",
            "startOffset": 35749,
            "title": "Vaccination with ChAdOx1 85A boosted ex-vivo Ag85A-specific IFN-\u03b3 responses that are further boosted by MVA85A"
        },
        {
            "endOffset": 34464,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Results"
                },
                {
                    "id": "s0065",
                    "title": "Vaccine immunogenicity"
                }
            ],
            "refoffsets": {
                "b0100": {
                    "endOffset": 34463,
                    "startOffset": 34459
                }
            },
            "secId": "s0070",
            "sentence": "AUC analysis for Ag85A-specific responses was performed on groups B and C and volunteers from a previous trial, TB022, who received MVA85A alone by intramuscular injection [20].",
            "startOffset": 34287,
            "title": "Vaccination with ChAdOx1 85A boosted ex-vivo Ag85A-specific IFN-\u03b3 responses that are further boosted by MVA85A"
        },
        {
            "endOffset": 29475,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0045",
            "sentence": "Non-recombinant MVA (1 \u00d7 107pfu/ml) and ChAdOx1 (5 \u00d7 106 IU/ml) (Vector Core Facility, Jenner Institute, Oxford) were used to measure vector-specific IgG responses.",
            "startOffset": 29311,
            "title": "Enzyme-linked immunosorbent assay (ELISA)"
        },
        {
            "endOffset": 30818,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0050",
            "sentence": "Area Under the Curve (AUC) analysis was used to detect difference over time.",
            "startOffset": 30742,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 39849,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Results"
                },
                {
                    "id": "s0065",
                    "title": "Vaccine immunogenicity"
                }
            ],
            "secId": "s0085",
            "sentence": "Boosting with ChAdOx1 85A at D28 enhanced the IgG fold change in Group C (p = 0.001 at D42) (Fig. 5I).",
            "startOffset": 39747,
            "title": "Immunoglobulin G (IgG) responses following ChAdOx1 85A and MVA85A vaccination"
        },
        {
            "endOffset": 22576,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0020",
            "sentence": "Latent Mycobacterium tuberculosis (M.tb) infection (LTBI) was excluded at screening with a negative IFN-\u03b3 release assay response to ESAT-6 and CFP-10, by means of the T Spot.TB kit (Oxford Immunotec, UK) or QuantiFERON\u00ae-TB Gold In-Tube.",
            "startOffset": 22340,
            "title": "Participants"
        },
        {
            "endOffset": 30380,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0050",
            "sentence": "Baseline demographics, AEs, ELISpot, WB ICS and antibody data were analysed using GraphPad Prism.",
            "startOffset": 30283,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 25189,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0030",
            "sentence": "Assignment of causality was conducted according to a pre-defined criteria specified in the protocol.",
            "startOffset": 25089,
            "title": "Clinical interventions"
        },
        {
            "endOffset": 23803,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0030",
            "sentence": "After successful safety review, the first Group A volunteer received ChAdOx1 85A at a dose of 2.5 \u00d7 1010 vp with safety review 48 h later.",
            "startOffset": 23665,
            "title": "Clinical interventions"
        },
        {
            "endOffset": 35504,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Results"
                },
                {
                    "id": "s0065",
                    "title": "Vaccine immunogenicity"
                }
            ],
            "secId": "s0070",
            "sentence": "Boosting with MVA85A significantly increased PPD-specific IFN-\u03b3 responses at D63 in Group B (p = 0.005) and D126 in Group C (p = 0.002), contracting to baseline at D84 and D147 (Groups B and C respectively).",
            "startOffset": 35297,
            "title": "Vaccination with ChAdOx1 85A boosted ex-vivo Ag85A-specific IFN-\u03b3 responses that are further boosted by MVA85A"
        },
        {
            "endOffset": 22650,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0020",
            "sentence": "The full inclusion and exclusion criteria are in Supplementary Methods 1.",
            "startOffset": 22577,
            "title": "Participants"
        },
        {
            "endOffset": 39746,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Results"
                },
                {
                    "id": "s0065",
                    "title": "Vaccine immunogenicity"
                }
            ],
            "secId": "s0085",
            "sentence": "Boosting with MVA85A resulted in increased IgG fold change in Group B at D84 (D84 v D14 p = 0.009; D84 v D28 p = 0.005 and D84 v D56 p = 0.0005) and Group C at D147 (D147 v D14 p = 0.001; D147 v D28 p = 0.002; D147 v D42 p = 0.024, D147 v D56 p = 0.0098 and D147 v D119 p = 0.001).",
            "startOffset": 39465,
            "title": "Immunoglobulin G (IgG) responses following ChAdOx1 85A and MVA85A vaccination"
        },
        {
            "endOffset": 20957,
            "parents": [],
            "refoffsets": {
                "b0090": {
                    "endOffset": 20956,
                    "startOffset": 20952
                }
            },
            "secId": "s0005",
            "sentence": "Preclinical murine studies have demonstrated ChAdOx1 85A to be consistently protective when used as part of a BCG-ChAdOx1 85A-MVA85A immunisation regime [18].",
            "startOffset": 20799,
            "title": "Background"
        },
        {
            "endOffset": 38525,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Results"
                },
                {
                    "id": "s0065",
                    "title": "Vaccine immunogenicity"
                }
            ],
            "secId": "s0080",
            "sentence": "A second ChAdOx1 85A vaccination did not boost the frequency of the Ag85A-specific polyfunctional CD4+ T cell responses.",
            "startOffset": 38405,
            "title": "Polyfunctional CD4+ and CD8+ T cells are detectable after ChAdOx1 85A and MVA85A vaccinations"
        },
        {
            "endOffset": 47105,
            "parents": [],
            "secId": "s0100",
            "sentence": "This research was supported by the Wellcome Trust (grant 095780/Z/11/Z awarded to HMcS), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre based at Oxford University Hospitals NHS Trust and University of Oxford, the European Union\u2019s Horizon 2020 research and innovation programme under grant agreement No 643381 (TBVAC2020), Aeras (MCA002), and the National Institute for Health Research Clinical Research Network Thames Valley and South Midlands (TVCLRN), and carried out at the University of Oxford and the National Institute for Health Research (NIHR)/Wellcome Trust Birmingham Clinical Research Facility.",
            "startOffset": 46463,
            "title": "Financial support statement"
        },
        {
            "endOffset": 39464,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Results"
                },
                {
                    "id": "s0065",
                    "title": "Vaccine immunogenicity"
                }
            ],
            "secId": "s0085",
            "sentence": "The magnitude of the measured IgG response was not ChAdOx1 85A dose-dependent (Supplementary Fig. 3I).",
            "startOffset": 39362,
            "title": "Immunoglobulin G (IgG) responses following ChAdOx1 85A and MVA85A vaccination"
        },
        {
            "endOffset": 35966,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Results"
                },
                {
                    "id": "s0065",
                    "title": "Vaccine immunogenicity"
                }
            ],
            "secId": "s0070",
            "sentence": "A second dose of ChAdOx1 85A (Group C) did not enhance this anti-vector specific response.",
            "startOffset": 35876,
            "title": "Vaccination with ChAdOx1 85A boosted ex-vivo Ag85A-specific IFN-\u03b3 responses that are further boosted by MVA85A"
        },
        {
            "endOffset": 18928,
            "parents": [],
            "secId": "s0005",
            "sentence": "The only licenced TB vaccine, Bacille Calmette-Gu\u00e9rin (BCG), is highly effective at preventing TB meningitis and disseminated disease in children.",
            "startOffset": 18782,
            "title": "Background"
        },
        {
            "endOffset": 34675,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Results"
                },
                {
                    "id": "s0065",
                    "title": "Vaccine immunogenicity"
                }
            ],
            "secId": "s0070",
            "sentence": "To account for the different time points in the groups, analysis was only performed using four time points, starting from 1 week post-MVA85A vaccination and including 4, 12 and 24 weeks post-MVA85A vaccination.",
            "startOffset": 34465,
            "title": "Vaccination with ChAdOx1 85A boosted ex-vivo Ag85A-specific IFN-\u03b3 responses that are further boosted by MVA85A"
        },
        {
            "endOffset": 32975,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "A Group C volunteer reported shingles in the T9 dermatomal distribution at D56, 28 days post D28 vaccination with ChAdOx1 85A.",
            "startOffset": 32849,
            "title": "Vaccine safety"
        },
        {
            "endOffset": 32688,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "There were 9 haematological AEs considered to be related to ChAdOx1 85A vaccination (lymphopaenia (3 mild), neutropaenia (1 mild, 1 moderate), leukopaenia (1 mild), eosinophilia (2 mild) and thrombocytopaenia (1 mild)) and 5 related to MVA85A (lymphopaenia (1 mild, 1 moderate), leukopaenia (2 mild) and eosinophilia (1 mild)).",
            "startOffset": 32361,
            "title": "Vaccine safety"
        },
        {
            "endOffset": 25441,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0030",
            "sentence": "Blood for exploratory immunology was taken at all visits.",
            "startOffset": 25384,
            "title": "Clinical interventions"
        },
        {
            "endOffset": 44146,
            "parents": [],
            "refoffsets": {
                "b0175": {
                    "endOffset": 44145,
                    "startOffset": 44138
                },
                "b0180": {
                    "endOffset": 44145,
                    "startOffset": 44138
                },
                "b0185": {
                    "endOffset": 44145,
                    "startOffset": 44138
                }
            },
            "secId": "s0090",
            "sentence": "Polyfunctional T cells have been shown to play a role in protection against intracellular pathogens and were shown to be induced by MVA85A vaccination [35\u201337].",
            "startOffset": 43987,
            "title": "Discussion:"
        },
        {
            "endOffset": 45413,
            "parents": [],
            "refoffsets": {
                "b0120": {
                    "endOffset": 45412,
                    "startOffset": 45405
                },
                "b0195": {
                    "endOffset": 45412,
                    "startOffset": 45405
                }
            },
            "secId": "s0090",
            "sentence": "Although the role of antibodies in control of TB is unclear, some studies have demonstrated a crucial role of antibodies in protection against infection and we have demonstrated that vaccine-induced Ag85A-specific IgG is associated with a reduced risk of TB disease [24,39].",
            "startOffset": 45139,
            "title": "Discussion:"
        },
        {
            "endOffset": 38152,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Results"
                },
                {
                    "id": "s0065",
                    "title": "Vaccine immunogenicity"
                }
            ],
            "secId": "s0080",
            "sentence": "Ag85A-specific CD4+ T cells producing combinations of IFN-\u03b3, TNF-\u03b1 and IL-2 (g+t+2+ ) (Fig. 4I), IFN-\u03b3 and TNF-\u03b1 (g+t+) (Fig. 4II) and IFN-\u03b3 and IL2 (g+2+) (Fig. 4III) were induced by ChAdOx1 85A in Groups A, B and C (Group A p = 0.005, Group B p = 0.001 and Group C p = 0.002 for g+t+2+; Group A p = 0.004, Group B p = 0.001 and Group C p = 0.0039 for g+t+; Group A p = 0.001, Group B and C p = 0.002 for g+2+ all D14 compared to D0).",
            "startOffset": 37717,
            "title": "Polyfunctional CD4+ and CD8+ T cells are detectable after ChAdOx1 85A and MVA85A vaccinations"
        },
        {
            "endOffset": 20197,
            "parents": [],
            "refoffsets": {
                "b0070": {
                    "endOffset": 20196,
                    "startOffset": 20192
                }
            },
            "secId": "s0005",
            "sentence": "This heterologous prime-boost regime was well-tolerated and induced increased frequency of antigen-specific CD4+ and CD8+ T-cell responses [14].",
            "startOffset": 20053,
            "title": "Background"
        },
        {
            "endOffset": 21639,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "It was registered with clinicaltrials.gov (ref NCT01829490) and conducted according to the principles of the Declaration of Helsinki and Good Clinical Practice.",
            "startOffset": 21479,
            "title": "Trial design"
        },
        {
            "endOffset": 43573,
            "parents": [],
            "refoffsets": {
                "b0145": {
                    "endOffset": 43572,
                    "startOffset": 43565
                },
                "b0150": {
                    "endOffset": 43572,
                    "startOffset": 43565
                },
                "b0155": {
                    "endOffset": 43572,
                    "startOffset": 43565
                }
            },
            "secId": "s0090",
            "sentence": "Studies in humans and animals have suggested a significant role of CD8+ T cells in control of TB [29\u201331].",
            "startOffset": 43468,
            "title": "Discussion:"
        },
        {
            "endOffset": 27130,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0040",
            "sentence": "Briefly, 500 \u00b5l WB was added to duplicate tubes containing either a pool of Ag85A peptides (66 15mer peptides, overlapping by 10 amino acids) at a final concentration of 2ug/ml, SEB at a final concentration of 5ug/ml (positive control) or tubes containing no antigen (negative control).",
            "startOffset": 26844,
            "title": "Whole blood intracellular cytokine staining (WB ICS)"
        },
        {
            "endOffset": 27833,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0040",
            "sentence": "Supernatant was discarded and cell pellet washed in 10 ml PBS and centrifuged at 1500 rpm for 7 mins.",
            "startOffset": 27732,
            "title": "Whole blood intracellular cytokine staining (WB ICS)"
        },
        {
            "endOffset": 43049,
            "parents": [],
            "secId": "s0090",
            "sentence": "ChAdOx1 85A did not enhance PPD IFN-\u03b3 responses; this might be attributed to the high PPD responses detected at baseline, which are expected in BCG-vaccinated individuals.",
            "startOffset": 42878,
            "title": "Discussion:"
        },
        {
            "endOffset": 23664,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "b0085": {
                    "endOffset": 23663,
                    "startOffset": 23659
                }
            },
            "secId": "s0030",
            "sentence": "A safety review was performed once all volunteers in this group had reached D14 to ensure no safety concerns before proceeding to the predicted optimal dose of ChAdOx1 85A based on the previous Flu study [17].",
            "startOffset": 23455,
            "title": "Clinical interventions"
        },
        {
            "endOffset": 37619,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Results"
                },
                {
                    "id": "s0065",
                    "title": "Vaccine immunogenicity"
                }
            ],
            "secId": "s0075",
            "sentence": "These responses were higher in group C than in group B (p = 0.0007) and remained significantly higher at the end of the follow-up for both groups (Group B: D0 vs D224 p = 0.01; Group C: D0 vs D203 p = 0.001).",
            "startOffset": 37411,
            "title": "Vaccination with ChAdOx1 85A induces intracellular cytokine responses in Ag85A-specific CD4+ and CD8+ T cells"
        },
        {
            "endOffset": 46436,
            "parents": [],
            "secId": "s0095",
            "sentence": "We have shown the vaccine to be well-tolerated when given alone or in combination with MVA85A, and that ChAdOx1 85A induces potent Ag85A specific CD4+ and CD8+ T cell responses which are boosted by MVA85A vaccination.",
            "startOffset": 46219,
            "title": "Conclusion"
        },
        {
            "endOffset": 28930,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0040",
            "sentence": "Total summed cytokines (IFN-\u03b3, TNF-\u03b1, IL-2 and IL-17 for CD4+ T cells and IFN-\u03b3 and TNF-\u03b1 for CD8+ T cells) responses are presented.",
            "startOffset": 28798,
            "title": "Whole blood intracellular cytokine staining (WB ICS)"
        },
        {
            "endOffset": 40023,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Results"
                },
                {
                    "id": "s0065",
                    "title": "Vaccine immunogenicity"
                }
            ],
            "secId": "s0085",
            "sentence": "Ag85A-specific IgG responses were not significantly different between Groups B and C (p > 0.05 at 1 and 4 weeks post-MVA85A vaccination) (Supplementary Fig. 3I and Fig. 5I).",
            "startOffset": 39850,
            "title": "Immunoglobulin G (IgG) responses following ChAdOx1 85A and MVA85A vaccination"
        },
        {
            "endOffset": 40152,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Results"
                },
                {
                    "id": "s0065",
                    "title": "Vaccine immunogenicity"
                }
            ],
            "secId": "s0085",
            "sentence": "Vaccination with 5 \u00d7 109 vp ChAdOx1 85A induced significant ChAdOx1-specific IgG in the Starter Group (p = 0.031 at D56 and D84).",
            "startOffset": 40023,
            "title": "Immunoglobulin G (IgG) responses following ChAdOx1 85A and MVA85A vaccination"
        },
        {
            "endOffset": 19648,
            "parents": [],
            "secId": "s0005",
            "sentence": "More potent regimens are therefore needed.",
            "startOffset": 19606,
            "title": "Background"
        },
        {
            "endOffset": 19605,
            "parents": [],
            "secId": "s0005",
            "sentence": "This was likely in part due to reduced immunogenicity seen in this setting.",
            "startOffset": 19530,
            "title": "Background"
        },
        {
            "endOffset": 28697,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0040",
            "sentence": "Polyfunctional cytokine immune responses were analyzed using Pestle and Spice software packages (http://exon.niaid.nih.gov/spice/).",
            "startOffset": 28566,
            "title": "Whole blood intracellular cytokine staining (WB ICS)"
        },
        {
            "endOffset": 30282,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0050",
            "sentence": "Safety was assessed by analysing frequency and severity of vaccine related local and systemic, solicited and unsolicited AEs, and summarised by frequency and severity of AEs using descriptive statistics.",
            "startOffset": 30079,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 42648,
            "parents": [],
            "refoffsets": {
                "b0070": {
                    "endOffset": 42647,
                    "startOffset": 42640
                },
                "b0100": {
                    "endOffset": 42647,
                    "startOffset": 42640
                }
            },
            "secId": "s0090",
            "sentence": "We have previously shown that potent Ag85A-specific immune responses were induced by MVA85A boosting of AERAS-402 vaccine in healthy UK adults, the magnitude of these boosted responses in the group that received two doses of AERAS-402 was comparable to those detected in Group C of the present trial (p = 0.176) and to a single dose of MVA85A (p = 0.728) [14,20].",
            "startOffset": 42285,
            "title": "Discussion:"
        },
        {
            "endOffset": 19529,
            "parents": [],
            "refoffsets": {
                "b0030": {
                    "endOffset": 19272,
                    "startOffset": 19266
                },
                "b0035": {
                    "endOffset": 19272,
                    "startOffset": 19266
                },
                "b0040": {
                    "endOffset": 19272,
                    "startOffset": 19266
                },
                "b0045": {
                    "endOffset": 19272,
                    "startOffset": 19266
                },
                "b0050": {
                    "endOffset": 19272,
                    "startOffset": 19266
                },
                "b0055": {
                    "endOffset": 19528,
                    "startOffset": 19524
                }
            },
            "secId": "s0005",
            "sentence": "Recombinant viral vectors have shown early promise in animal and human studies [6\u201310], however the first efficacy trial with recombinant Modified Vaccinia virus Ankara (MVA85A) expressing the highly conserved, immunodominant, Mycobacterial antigen 85A (Ag85A) did not confer additional protection over BCG alone in South African infants [11].",
            "startOffset": 19187,
            "title": "Background"
        },
        {
            "endOffset": 22838,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "b0080": {
                    "endOffset": 22837,
                    "startOffset": 22833
                }
            },
            "secId": "s0025",
            "sentence": "ChAdOx1 85A (lot no. 02N12-01) was constructed under Good Manufacturing Practice (GMP) conditions at the Clinical Biomanufacturing Facility (CBF), University of Oxford, UK [16].",
            "startOffset": 22661,
            "title": "Vaccines"
        },
        {
            "endOffset": 26408,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0035",
            "sentence": "Anti-vector responses were measured using ChAdOx1 (2 IU:1 PBMC) (Vector Core Facility, The Jenner Institute, Oxford, UK) and responses to MVA were measured using separate pools of CD4 (27 14-21mer peptides) and CD8 (36 9mer peptides) epitopes from Vaccinia and MVA (Peptide Protein research, UK) (final concentration 2 \u03bcg/ml) and Purified Protein Derivative (PPD) (Statens Serum Institute, Denmark) (20 \u03bcg/ml).",
            "startOffset": 25998,
            "title": "Enzyme-Linked ImmunoSpot (ELISpot)"
        },
        {
            "endOffset": 33170,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "Due to the timing of the event and past medical history (volunteer had experienced two previous episodes of shingles several years prior to enrolment) this was deemed not related to vaccination.",
            "startOffset": 32976,
            "title": "Vaccine safety"
        },
        {
            "endOffset": 43771,
            "parents": [],
            "refoffsets": {
                "b0100": {
                    "endOffset": 43770,
                    "startOffset": 43766
                }
            },
            "secId": "s0090",
            "sentence": "Vaccination with ChAdOx1 85A resulted in significant Ag85A-specific IFN-\u03b3+ TNF-\u03b1+ CD8+ T cells which were boosted by MVA85A, previously reported to be a poor inducer of CD8+ T cells responses [20].",
            "startOffset": 43574,
            "title": "Discussion:"
        },
        {
            "endOffset": 31321,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "Local and systemic AEs were expected and mild in nature (Table 1).",
            "startOffset": 31255,
            "title": "Vaccine safety"
        },
        {
            "endOffset": 24801,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0030",
            "sentence": "Expected local and systemic solicited and unsolicited adverse events (AEs) were collected by volunteers using a 7-day diary-card, and reviewed by the clinical team at follow-up visits along with vital signs.",
            "startOffset": 24594,
            "title": "Clinical interventions"
        },
        {
            "endOffset": 41347,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Results"
                },
                {
                    "id": "s0065",
                    "title": "Vaccine immunogenicity"
                }
            ],
            "secId": "s0085",
            "sentence": "MVA85A vaccination induced anti-MVA IgG that peaked two weeks after vaccination and remained significantly higher than D0 in both Groups B (D63 p = 0.005; D84 and D140 p = 0.0005 and D224 p = 0.002) and Group C (D126 p = 0.002, D147 p = 0.0005 and D287 p = 0.001) (Supplementary Fig. 3III).",
            "startOffset": 41057,
            "title": "Immunoglobulin G (IgG) responses following ChAdOx1 85A and MVA85A vaccination"
        },
        {
            "endOffset": 35075,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Results"
                },
                {
                    "id": "s0065",
                    "title": "Vaccine immunogenicity"
                }
            ],
            "secId": "s0070",
            "sentence": "AUC analysis comparing the Starter Group with Group A was not significant",
            "startOffset": 35002,
            "title": "Vaccination with ChAdOx1 85A boosted ex-vivo Ag85A-specific IFN-\u03b3 responses that are further boosted by MVA85A"
        },
        {
            "endOffset": 25869,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "b0070": {
                    "endOffset": 25818,
                    "startOffset": 25814
                }
            },
            "secId": "s0035",
            "sentence": "IFN-\u03b3 ex-vivo ELISpot was performed on freshly isolated Peripheral Blood Mononuclear Cells (PBMC) from volunteers in the Starter Group and Group A at: D0, D14, D28, D56, D84 and D168, Group B at: D0, D14, D28, D56, D63, D84, D140 and D224 and Group C at: D0, D14, D28, D42, D56, D119, D126, D147, D203 and D287, as previously described [14] using the Human IFN-\u03b3 ELISpot (ALP) kit (Mabtech).",
            "startOffset": 25478,
            "title": "Enzyme-Linked ImmunoSpot (ELISpot)"
        },
        {
            "endOffset": 29913,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0045",
            "sentence": "pNPP substrate (Sigma) was used for detection of IgG and the reaction stopped with 3 M NaOH.",
            "startOffset": 29821,
            "title": "Enzyme-linked immunosorbent assay (ELISA)"
        },
        {
            "endOffset": 36354,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Results"
                },
                {
                    "id": "s0065",
                    "title": "Vaccine immunogenicity"
                }
            ],
            "secId": "s0070",
            "sentence": "Responses to CD4+ T cell epitopes were detectable in Group B, one and four weeks post-MVA85A vaccination (p = 0.033 and p = 0.012 respectively) (Fig. 2III).",
            "startOffset": 36198,
            "title": "Vaccination with ChAdOx1 85A boosted ex-vivo Ag85A-specific IFN-\u03b3 responses that are further boosted by MVA85A"
        },
        {
            "endOffset": 24593,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0030",
            "sentence": "All volunteers had a clinical review 30 and 60 min following vaccination.",
            "startOffset": 24520,
            "title": "Clinical interventions"
        },
        {
            "endOffset": 28409,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0040",
            "sentence": "Data was acquired on an LSRII (Becton Dickinson), Instrument daily performance was monitored using Cytometer Setting and Tracking Beads.",
            "startOffset": 28273,
            "title": "Whole blood intracellular cytokine staining (WB ICS)"
        },
        {
            "endOffset": 28272,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0040",
            "sentence": "Samples were thawed, permeabilised and incubated with antibodies against CD3 (AF700), IFN-\u03b3 (PE\u2013Cy7) (Ebioscience), CD4 (Pacific Blue), TNF-\u03b1 (AF647), IL-17 (AF488) (Biolegend), CD8 (APC-H7) (Becton Dickinson), IL-2 (PE), CD14 (ECD) and CD19 (ECD) (Beckman Coulter).",
            "startOffset": 28006,
            "title": "Whole blood intracellular cytokine staining (WB ICS)"
        },
        {
            "endOffset": 42284,
            "parents": [],
            "secId": "s0090",
            "sentence": "AUC analysis of the Ag85A-specific IFN-\u03b3 ELISpot response 1-24 weeks after vaccination with MVA85A showed no significant difference between Group B and Group C, although both had higher median AUC responses than a previous trial of MVA85A when given alone.",
            "startOffset": 42028,
            "title": "Discussion:"
        },
        {
            "endOffset": 36197,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Results"
                },
                {
                    "id": "s0065",
                    "title": "Vaccine immunogenicity"
                }
            ],
            "secId": "s0070",
            "sentence": "No MVA-specific responses were detectable in Starter Group and Group A. Group B and C had significantly higher responses to the MVA CD8+ T cell epitopes one week following MVA85A vaccination (Group B p = 0.034; Group C p = 0.0098).",
            "startOffset": 35966,
            "title": "Vaccination with ChAdOx1 85A boosted ex-vivo Ag85A-specific IFN-\u03b3 responses that are further boosted by MVA85A"
        },
        {
            "endOffset": 47267,
            "parents": [],
            "secId": "s0100",
            "sentence": "HMcS is a Jenner Institute Investigator.",
            "startOffset": 47227,
            "title": "Financial support statement"
        },
        {
            "endOffset": 22168,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0020",
            "sentence": "Volunteers were healthy, aged between 18 and 55, and had received BCG vaccination from an independent source prior to screening (no less than 6 months prior to date of enrolment).",
            "startOffset": 21989,
            "title": "Participants"
        },
        {
            "endOffset": 26843,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "b0095": {
                    "endOffset": 26842,
                    "startOffset": 26838
                }
            },
            "secId": "s0040",
            "sentence": "The assay was performed on fresh samples as previously described [19].",
            "startOffset": 26773,
            "title": "Whole blood intracellular cytokine staining (WB ICS)"
        },
        {
            "endOffset": 25383,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0030",
            "sentence": "Safety bloods were taken 14 days following ChAdOx1 85A and 7 days following MVA85A, with bloods also taken on the day of 2nd and 3rd vaccinations depending on the individual volunteer schedule.",
            "startOffset": 25190,
            "title": "Clinical interventions"
        },
        {
            "endOffset": 33743,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Results"
                },
                {
                    "id": "s0065",
                    "title": "Vaccine immunogenicity"
                }
            ],
            "secId": "s0070",
            "sentence": "Responses peaked at D14 (Fig. 2I; p = 0.0005 for Groups A, B and C), and remained significantly higher than baseline until the end of follow-up (D168 in Group A (p = 0.003).",
            "startOffset": 33570,
            "title": "Vaccination with ChAdOx1 85A boosted ex-vivo Ag85A-specific IFN-\u03b3 responses that are further boosted by MVA85A"
        },
        {
            "endOffset": 33267,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "There were no Serious Adverse Events (SAEs) reported during the course of the study in any group.",
            "startOffset": 33170,
            "title": "Vaccine safety"
        },
        {
            "endOffset": 41057,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Results"
                },
                {
                    "id": "s0065",
                    "title": "Vaccine immunogenicity"
                }
            ],
            "secId": "s0085",
            "sentence": "Two doses of ChAdOx1 85A induced higher fold change in Group C (D28 vs D56 peak fold change p = 0.0005; Fig. 5II).",
            "startOffset": 40943,
            "title": "Immunoglobulin G (IgG) responses following ChAdOx1 85A and MVA85A vaccination"
        },
        {
            "endOffset": 32849,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "All others resolved fully.",
            "startOffset": 32823,
            "title": "Vaccine safety"
        },
        {
            "endOffset": 21771,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0020",
            "sentence": "Volunteers were recruited from the Oxford and Birmingham area, providing written informed consent prior to screening.",
            "startOffset": 21654,
            "title": "Participants"
        },
        {
            "endOffset": 31557,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "Two volunteers in Group B reported severe pain at vaccination site following MVA85A vaccination at D56.",
            "startOffset": 31454,
            "title": "Vaccine safety"
        },
        {
            "endOffset": 41570,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Results"
                },
                {
                    "id": "s0065",
                    "title": "Vaccine immunogenicity"
                }
            ],
            "secId": "s0085",
            "sentence": "Fold change MVA-specific IgG response was significantly induced in both Groups B and C (p = 0.0005 for D84 and D140 Group B and D147 Group C; p = 0.002 for D224 Group B and p = 0.001 for D126 and D287 Group C) (Fig. 5III).",
            "startOffset": 41348,
            "title": "Immunoglobulin G (IgG) responses following ChAdOx1 85A and MVA85A vaccination"
        },
        {
            "endOffset": 46218,
            "parents": [],
            "secId": "s0095",
            "sentence": "This is the first study of the safety and immunogenicity of ChAdOx1 85A in humans.",
            "startOffset": 46136,
            "title": "Conclusion"
        },
        {
            "endOffset": 43467,
            "parents": [],
            "secId": "s0090",
            "sentence": "Production of these cytokines was also induced by ChAdOx1 85A and boosted by MVA85A.",
            "startOffset": 43383,
            "title": "Discussion:"
        },
        {
            "endOffset": 25997,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0035",
            "sentence": "Ag85A-specific responses were measured using a single pool of Ag85A peptides (66 15mer peptides, overlapping by 10 amino acids).",
            "startOffset": 25869,
            "title": "Enzyme-Linked ImmunoSpot (ELISpot)"
        },
        {
            "endOffset": 31993,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "Of those who reported a severe systemic AE (n = 4); one volunteer in Group A reported severe fatigue, feverishness and headache, and one in Group B reported severe feverishness and fatigue, all following D0 ChAdOx1 85A.",
            "startOffset": 31774,
            "title": "Vaccine safety"
        },
        {
            "endOffset": 27443,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0040",
            "sentence": "Tubes were then incubated at 37 \u00b0C in a water bath timed to switch off after 6 h.",
            "startOffset": 27362,
            "title": "Whole blood intracellular cytokine staining (WB ICS)"
        },
        {
            "endOffset": 41795,
            "parents": [],
            "secId": "s0090",
            "sentence": "In this phase I first-in-human clinical trial, we found that vaccination with candidate TB vaccine ChAdOx1 85A was well tolerated up to a dose of 2.5 \u00d7 1010 vp, with an acceptable safety profile across all groups.",
            "startOffset": 41582,
            "title": "Discussion:"
        },
        {
            "endOffset": 44917,
            "parents": [],
            "secId": "s0090",
            "sentence": "A single dose of ChAdOx1 85A induced ChAdOx1-specific IFN-\u03b3 responses but were not boosted by homologous vaccination.",
            "startOffset": 44800,
            "title": "Discussion:"
        }
    ],
    "docId": "S0264410X1931504X",
    "metadata": {
        "asjc": [
            "1313",
            "2400",
            "2725",
            "2739",
            "3400"
        ],
        "authors": [
            {
                "email": null,
                "first": "Morven",
                "initial": "M.",
                "last": "Wilkie"
            },
            {
                "email": null,
                "first": "Iman",
                "initial": "I.",
                "last": "Satti"
            },
            {
                "email": null,
                "first": "Alice",
                "initial": "A.",
                "last": "Minhinnick"
            },
            {
                "email": null,
                "first": "Stephanie",
                "initial": "S.",
                "last": "Harris"
            },
            {
                "email": null,
                "first": "Michael",
                "initial": "M.",
                "last": "Riste"
            },
            {
                "email": null,
                "first": "Raquel Lopez",
                "initial": "R.L.",
                "last": "Ramon"
            },
            {
                "email": null,
                "first": "Sharon",
                "initial": "S.",
                "last": "Sheehan"
            },
            {
                "email": null,
                "first": "Zita Rose Manjaly",
                "initial": "Z.R.M.",
                "last": "Thomas"
            },
            {
                "email": null,
                "first": "Daniel",
                "initial": "D.",
                "last": "Wright"
            },
            {
                "email": null,
                "first": "Lisa",
                "initial": "L.",
                "last": "Stockdale"
            },
            {
                "email": null,
                "first": "Ali",
                "initial": "A.",
                "last": "Hamidi"
            },
            {
                "email": null,
                "first": "Matthew K.",
                "initial": "M.K.",
                "last": "O'Shea"
            },
            {
                "email": null,
                "first": "Kritica",
                "initial": "K.",
                "last": "Dwivedi"
            },
            {
                "email": null,
                "first": "Hannah Michaela",
                "initial": "H.M.",
                "last": "Behrens"
            },
            {
                "email": null,
                "first": "Tamara",
                "initial": "T.",
                "last": "Davenne"
            },
            {
                "email": null,
                "first": "Joshua",
                "initial": "J.",
                "last": "Morton"
            },
            {
                "email": null,
                "first": "Samantha",
                "initial": "S.",
                "last": "Vermaak"
            },
            {
                "email": null,
                "first": "Alison",
                "initial": "A.",
                "last": "Lawrie"
            },
            {
                "email": null,
                "first": "Paul",
                "initial": "P.",
                "last": "Moss"
            },
            {
                "email": "helen.mcshane@ndm.ox.ac.uk",
                "first": "Helen",
                "initial": "H.",
                "last": "McShane"
            }
        ],
        "doi": "10.1016/j.vaccine.2019.10.102",
        "firstpage": "779",
        "issn": "0264410X",
        "keywords": [
            "ChAdOx1 85A",
            "Immunogenicity",
            "MVA85A",
            "Safety",
            "Tuberculosis",
            "Vaccine"
        ],
        "lastpage": "789",
        "openaccess": "Full",
        "pub_year": 2020,
        "subjareas": [
            "BIOC",
            "IMMU",
            "MEDI",
            "VETE"
        ],
        "title": "A phase I trial evaluating the safety and immunogenicity of a candidate tuberculosis vaccination regimen, ChAdOx1 85A prime \u2013 MVA85A boost in healthy UK adults"
    }
}